| Package | tewhatuora.nzhts |
| Type | ImplementationGuide |
| Id | Id |
| FHIR Version | R4 |
| Source | fhir-ig.digital.health.nz/nzhts/https://build.fhir.org/ig/daniel-thomson/nzhts/index.html |
| Url | fhir-ig.digital.health.nz/nzhts/ImplementationGuide/tewhatuora.nzhts |
| Version | 0.1.0 |
| Status | draft |
| Date | 2024-07-29T04:31:37+00:00 |
| Name | nzhts |
| Title | New Zealand Health Terminology Service (NZHTS) Implementation Guide |
| Experimental | False |
| Authority | national |
| Description | FHIR Iimplementation Guide for the NZHTS generated from the NZHTS API |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ImplementationGuide tewhatuora.nzhts
The official URL for this implementation guide is:
fhir-ig.digital.health.nz/nzhts/ImplementationGuide/tewhatuora.nzhts
FHIR Iimplementation Guide for the NZHTS generated from the NZHTS API
FHIR{
"resourceType" : "ImplementationGuide",
"id" : "tewhatuora.nzhts",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ImplementationGuide tewhatuora.nzhts</b></p><a name=\"tewhatuora.nzhts\"> </a><a name=\"hctewhatuora.nzhts\"> </a><a name=\"tewhatuora.nzhts-en-US\"> </a><h2>nzhts</h2><p>The official URL for this implementation guide is: </p><pre>fhir-ig.digital.health.nz/nzhts/ImplementationGuide/tewhatuora.nzhts</pre><div><p>FHIR Iimplementation Guide for the NZHTS generated from the NZHTS API</p>\n</div></div>"
},
"url" : "fhir-ig.digital.health.nz/nzhts/ImplementationGuide/tewhatuora.nzhts",
"version" : "0.1.0",
"name" : "nzhts",
"title" : "New Zealand Health Terminology Service (NZHTS) Implementation Guide",
"status" : "draft",
"date" : "2024-07-29T04:31:37+00:00",
"publisher" : "Health New Zealand | Te Whatu Ora",
"contact" : [
{
"name" : "Health New Zealand | Te Whatu Ora",
"telecom" : [
{
"system" : "url",
"value" : "https://www.tewhatuora.govt.nz/"
}
]
}
],
"description" : "FHIR Iimplementation Guide for the NZHTS generated from the NZHTS API",
"packageId" : "tewhatuora.nzhts",
"license" : "CC0-1.0",
"fhirVersion" : [
"4.0.1"
],
"dependsOn" : [
{
"id" : "hl7tx",
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/implementationguide-dependency-comment",
"valueMarkdown" : "Automatically added as a dependency - all IGs depend on HL7 Terminology"
}
],
"uri" : "http://terminology.hl7.org/ImplementationGuide/hl7.terminology",
"packageId" : "hl7.terminology.r4",
"version" : "6.0.2"
},
{
"id" : "hl7ext",
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/implementationguide-dependency-comment",
"valueMarkdown" : "Automatically added as a dependency - all IGs depend on the HL7 Extension Pack"
}
],
"uri" : "http://hl7.org/fhir/extensions/ImplementationGuide/hl7.fhir.uv.extensions",
"packageId" : "hl7.fhir.uv.extensions.r4",
"version" : "5.1.0"
}
],
"definition" : {
"extension" : [
{
"extension" : [
{
"url" : "code",
"valueString" : "copyrightyear"
},
{
"url" : "value",
"valueString" : "2024+"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "releaselabel"
},
{
"url" : "value",
"valueString" : "ci-build"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-narrative"
},
{
"url" : "value",
"valueString" : "CodeSystem/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-narrative"
},
{
"url" : "value",
"valueString" : "ValueSet/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-narrative"
},
{
"url" : "value",
"valueString" : "ConceptMap/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-validate"
},
{
"url" : "value",
"valueString" : "CodeSystem/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-validate"
},
{
"url" : "value",
"valueString" : "ValueSet/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-validate"
},
{
"url" : "value",
"valueString" : "ConceptMap/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-check-usage"
},
{
"url" : "value",
"valueString" : "CodeSystem/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-check-usage"
},
{
"url" : "value",
"valueString" : "ValueSet/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "no-check-usage"
},
{
"url" : "value",
"valueString" : "ConceptMap/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "autoload-resources"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-liquid"
},
{
"url" : "value",
"valueString" : "template/liquid"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-liquid"
},
{
"url" : "value",
"valueString" : "input/liquid"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-qa"
},
{
"url" : "value",
"valueString" : "temp/qa"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-temp"
},
{
"url" : "value",
"valueString" : "temp/pages"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-output"
},
{
"url" : "value",
"valueString" : "output"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-suppressed-warnings"
},
{
"url" : "value",
"valueString" : "input/ignoreWarnings.txt"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-history"
},
{
"url" : "value",
"valueString" : "fhir-ig.digital.health.nz/nzhts/history.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "template-html"
},
{
"url" : "value",
"valueString" : "template-page.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "template-md"
},
{
"url" : "value",
"valueString" : "template-page-md.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-contact"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-context"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-copyright"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-jurisdiction"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-license"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-publisher"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-version"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-wg"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "active-tables"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "fmm-definition"
},
{
"url" : "value",
"valueString" : "http://hl7.org/fhir/versions.html#maturity"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "propagate-status"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "excludelogbinaryformat"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "tabbed-snapshots"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-internal-dependency",
"valueCode" : "hl7.fhir.uv.tools#0.1.0"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "copyrightyear"
},
{
"url" : "value",
"valueString" : "2024+"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "releaselabel"
},
{
"url" : "value",
"valueString" : "ci-build"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-narrative"
},
{
"url" : "value",
"valueString" : "CodeSystem/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-narrative"
},
{
"url" : "value",
"valueString" : "ValueSet/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-narrative"
},
{
"url" : "value",
"valueString" : "ConceptMap/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-validate"
},
{
"url" : "value",
"valueString" : "CodeSystem/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-validate"
},
{
"url" : "value",
"valueString" : "ValueSet/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-validate"
},
{
"url" : "value",
"valueString" : "ConceptMap/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-check-usage"
},
{
"url" : "value",
"valueString" : "CodeSystem/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-check-usage"
},
{
"url" : "value",
"valueString" : "ValueSet/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "no-check-usage"
},
{
"url" : "value",
"valueString" : "ConceptMap/*"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "autoload-resources"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-liquid"
},
{
"url" : "value",
"valueString" : "template/liquid"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-liquid"
},
{
"url" : "value",
"valueString" : "input/liquid"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-qa"
},
{
"url" : "value",
"valueString" : "temp/qa"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-temp"
},
{
"url" : "value",
"valueString" : "temp/pages"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-output"
},
{
"url" : "value",
"valueString" : "output"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-suppressed-warnings"
},
{
"url" : "value",
"valueString" : "input/ignoreWarnings.txt"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "path-history"
},
{
"url" : "value",
"valueString" : "fhir-ig.digital.health.nz/nzhts/history.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "template-html"
},
{
"url" : "value",
"valueString" : "template-page.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "template-md"
},
{
"url" : "value",
"valueString" : "template-page-md.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-contact"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-context"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-copyright"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-jurisdiction"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-license"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-publisher"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-version"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "apply-wg"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "active-tables"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "fmm-definition"
},
{
"url" : "value",
"valueString" : "http://hl7.org/fhir/versions.html#maturity"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "propagate-status"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "excludelogbinaryformat"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueCode" : "tabbed-snapshots"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
}
],
"resource" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/046609aa-c4d8-4dbd-add5-cd65164d4d45"
},
"name" : "Clinical code type code",
"description" : "Clinical code type code for use when reporting into National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/05d9a401-d679-413f-887f-4008a3977ffd"
},
"name" : "Admission type code",
"description" : "Admission types to be used for reporting into National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/0b2c2a2a-0ea2-4a63-96f4-cc02c7c4ea23"
},
"name" : "Agency type code",
"description" : "Agency type code to be used in reporting to National Collection",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/0d325e55-1bc7-4491-abd6-b678bf676d8a"
},
"name" : "Clinical coding system code",
"description" : "Clinical coding system code to be used in reporting to national Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/0e6f78ad-7d02-484c-b930-0677e78ad7b5"
},
"name" : "Clinical code type code",
"description" : "Clinical code type to be used in reporting to National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/1587f987-b621-4494-b76d-cbad95f862c7"
},
"name" : "Uterotonic drugs administered status code",
"description" : "HISO 10050 Uterotonic drugs administered status, as part of the third stage of labour.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/178d6377-a1db-4992-b303-ff41d46a25bc"
},
"name" : "Admission type code",
"description" : "Admission type code for reporting into National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/1b07c104-36ce-4c8e-a00d-6449d6b70e72"
},
"name" : "99NZREL-Relationship",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/1f53d2e6-43e7-4a6f-8162-a8cbbdcaf7e4"
},
"name" : "AIR vaccine product",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/2368312e-e623-465d-a599-76336f03d2cf"
},
"name" : "Infant feeding method code",
"description" : "The feeding method of an infant at various stages post delivery",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/26bb5eb0-11c0-4f53-a9dc-6dbf2c18dfd0"
},
"name" : "Smoking status",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/2b7e5c24-4a1f-4271-9acf-9bc26338d576"
},
"name" : "Clinical coding system code",
"description" : "Clinical coding system code to be used for reporting to National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/321084b7-0be9-4e8c-bea6-613de1dfb3d4"
},
"name" : "Admission source code",
"description" : "Codes used for admission source that are required to be reporting into National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/34ae65c2-7799-4157-9ba3-c8a9c0bc404f"
},
"name" : "DSM-IV",
"description" : "DSM-IV",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/3520735b-dfc0-437d-81d1-4668ffdac620"
},
"name" : "Health service type refset vs",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/36d65fe3-ec80-48ad-af71-604abd675687"
},
"name" : "Domicile Code",
"description" : "Te Whatu Ora list of domicile codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/48fce1ed-33a9-4856-9d9b-aa228b40b771"
},
"name" : "Coverage Type",
"description" : "New Zealand codes for Coverage Types",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/4f1fd9c0-b6f7-46ba-acec-155be34d15fc"
},
"name" : "AIR status reason code",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/64b2cd2a-d092-4b24-8a95-e7a1a2c1dd3c"
},
"name" : "NZ ethnic group code level 4",
"description" : "All level 4 NZ ethnic groups according to Stats NZ.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/64e8120b-0cf3-46a3-83c0-34bce9e299e7"
},
"name" : "Agency type code",
"description" : "Agency type code to be used to reporting to National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/6a49d287-a077-454b-90cd-14d56e0ab089"
},
"name" : "AIR route of administration",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/7cb97863-abf1-419f-8c4a-005adb789c18"
},
"name" : "AIR vaccinator function",
"description" : "A value set of codes for the functions performed by vaccinators.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/7d2ebb5d-7957-4ee1-951b-6f5632b82e5e"
},
"name" : "Number of cord vessels code",
"description" : "Number of vessels identified in the umbilical cord",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/87ef165b-b4fe-4944-bb0a-db6305063d3c"
},
"name" : "DSM-IV",
"description" : "DSM-IV",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/8f4c29fa-c09b-4e33-86e2-2780c3af3aa2"
},
"name" : "NZ Residency Information Source",
"description" : "A coded type for the source of information for NZ residency",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/93753db5-d066-4452-8ef8-76c20c781a9b"
},
"name" : "Temporary rheumatic fever codes",
"description" : "SNOMED CT identifiers assigned to Rheumatic Fever concepts that will not be available until April 2024 edition. Codesystem need to be retired once they have been uploaded in SNOMED NZ Edition",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/AntiviralEligibilityCriteriaCode"
},
"name" : "Antiviral eligibility - criteria codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/AntiviralEligibilitySymptomsStarted"
},
"name" : "Antiviral eligibility symptoms started",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/AntiviralEligibilityWhenSymptomsStartedCodes"
},
"name" : "Antiviral eligibility - when symptoms started codes",
"description" : "Terms for clinicians to identify when symptoms started to determine if a person is eligible for the COVID-19 antiviral",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/CVX"
},
"name" : "Vaccine Administered Code Set (CVX)",
"description" : "The CDC's National Center of Immunization and Respiratory Diseases developed and maintains the CVX (vaccine administered) code set. It includes both active and inactive vaccines available in the US.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/Ethnicity"
},
"name" : "NZ ethnic group codes",
"description" : "A FHIR CodeSystem of Australian and Ethnicity New Zealand Standard Classification",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/Ethnicityfull"
},
"name" : "Ethnicity of a person (full)",
"description" : "NZ ethnic group codes that cover every ethnicity level",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/ISO3166Part1"
},
"name" : "ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code",
"description" : "ISO 3166-1 establishes codes that represent the current names of countries, dependencies, and other areas of particular geopolitical interest, on the basis of country names obtained from the United Nations.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/MaoriDescentValueset"
},
"name" : "MÄori descent codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/NZRhFCarePlanCategory"
},
"name" : "Rheumatic fever care plan category",
"description" : "Value set to support FHIR resource for identifying the rheumatic fever care plan being provided.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/NZRhFCareTeamParticipantRole"
},
"name" : "Rheumatic fever care team participant role",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/NZRhFDiagnosticCertaintyCS"
},
"name" : "Rheumatic fever diagnostic certainty",
"description" : "This list to support rheumatic fever collection.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/NZRhFDiagnosticCertaintyVS"
},
"name" : "Rheumatic fever diagnostic certainty",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/NZRhFMedicationAllergy"
},
"name" : "Rheumatic fever medication allergy",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/NZRhFRHDSeverityVS"
},
"name" : "Rheumatic fever rheumatic heart disease severity",
"description" : "The value set to support rheumatic fever data collection.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/OralEnrolmentTerminationReason"
},
"name" : "Oral health enrolment termination reason code",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/aae877cc-e7a2-49fc-bc92-3e010b6cb70f"
},
"name" : "NZPS Observation Vaping Status",
"description" : "ValueSet for Vaping Status based on the New Zealand vaping status reference set.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/absent-or-unknown-allergies-uv-ips"
},
"name" : "Absent or Unknown Allergies - IPS",
"description" : "Absent or Unknown Allergies",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/absent-or-unknown-devices-uv-ips"
},
"name" : "Absent or Unknown Devices - IPS",
"description" : "Absent or Unknown Devices",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/absent-or-unknown-immunizations-uv-ips"
},
"name" : "Absent or Unknown Immunization - IPS",
"description" : "Absent or Unknown Immunization",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/absent-or-unknown-medications-uv-ips"
},
"name" : "Absent or Unknown Medication - IPS",
"description" : "Absent or Unknown Medication",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/absent-or-unknown-problems-uv-ips"
},
"name" : "Absent or Unknown Problems - IPS",
"description" : "Absent or Unknown Problems",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/absent-or-unknown-procedures-uv-ips"
},
"name" : "Absent or Unknown Procedures - IPS",
"description" : "Absent or Unknown Procedures",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/administrative-gender"
},
"name" : "AdministrativeGender",
"description" : "The gender of a person used for administrative purposes.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/adverse-event-severity"
},
"name" : "AdverseEventSeverity",
"description" : "The severity of the adverse event itself, in direct relation to the subject.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/alias-type"
},
"name" : "Type of Alias",
"description" : "Used in Organization and Location to indicate what is the type of Alias",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/allergy-intolerance-category"
},
"name" : "AllergyIntoleranceCategory",
"description" : "Category of an identified substance associated with allergies or intolerances.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/allergy-intolerance-criticality"
},
"name" : "AllergyIntoleranceCriticality",
"description" : "Estimate of the potential clinical harm, or seriousness, of a reaction to an identified substance.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/allergy-intolerance-substance-condition-uv-ips"
},
"name" : "Allergy Intolerance Substance Condition - IPS",
"description" : "IPS Allergy intolerance substance condition value set. This value set includes codes from SNOMED Clinical Terms®: all descendants of 373873005 \\|Pharmaceutical / biologic product (product)\\|; all descendants of 105590001 \\|Substance (substance)\\|; all descendants of 418038007 \\|Propensity to adverse reactions to substance (finding)\\|",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/allergy-intolerance-type"
},
"name" : "AllergyIntoleranceType",
"description" : "Identification of the underlying physiological mechanism for a Reaction Risk.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/allergy-intolerance-uv-ips"
},
"name" : "Allergy Intolerance - IPS",
"description" : "IPS Allergy intolerance codes value set. This value set includes codes from SNOMED Clinical Terms®: all descendants of 373873005 \\|Pharmaceutical / biologic product (product)\\|; all descendants of 105590001 \\|Substance (substance)\\|; all descendants of 418038007 \\|Propensity to adverse reactions to substance (finding)\\| plus codes for absent and unknown allergies.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/allergy-reaction-snomed-ct-ips-free-set"
},
"name" : "Allergy Reaction - SNOMED CT IPS Free Set",
"description" : "IPS allergy reaction value set. This value set includes the codes from the SNOMED International Patient Set (IPS) subset of SNOMED CT (IPS Free Set) that may be used to represent allergy or intolerance reactions.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/allergyintolerance-clinical"
},
"name" : "AllergyIntolerance Clinical Status Codes",
"description" : "Preferred value set for AllergyIntolerance Clinical Status.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/anzsco"
},
"name" : "ANZSCO",
"description" : "A FHIR CodeSystem of Australian and New Zealand Standard Classification of Occupations",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/b4f184bd-bda7-43b2-899d-dca049b16286"
},
"name" : "AIR legacy codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/bdcd6e18-fc79-4b13-9219-80a5ce68631f"
},
"name" : "ANZSCO",
"description" : "Australian and New Zealand Standard Classification of Occupations (ANZSCO)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/body-site-uv-ips"
},
"name" : "Body Site - IPS",
"description" : "IPS body site value set. This value set includes a set of codes from SNOMED CT that may be used to represent body sites (e.g., for laboratory specimen collection).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/c92c5a8a-c89c-4644-8400-56c85f7b43fa"
},
"name" : "ISO 639-3 language codes",
"description" : "ISO 639-3 language codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-AJCC8-residual-tumour-clincal"
},
"name" : "NZ AJCC 8th edition residual tumour category clinical",
"description" : "Residual tumour values on structured pathology request form (surgeon) to remove R1 - Microscopic residual tumour based on AJCC 8th edition.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-AJCC8-residual-tumour"
},
"name" : "NZ AJCC (8th edition) edition residual tumour category",
"description" : "AJCC (8th edition) residual tumour (R) category.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-acute-leukaemia-cancer-type"
},
"name" : "NZ cancer acute leukaemia cancer type",
"description" : "The type of acute leukaemia haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-adjacent-organ-invasion"
},
"name" : "NZ cancer adjacent organ invasion",
"description" : "Whether or not it has been identified that the tumour has invaded into adjacent organs",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-ajcc-staging-manual-edition"
},
"name" : "NZ AJCC cancer staging manual edition",
"description" : "A numbered edition of the AJCC (AJCC)'s cancer staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-ann-arbor-lymphoma-stage"
},
"name" : "NZ cancer Ann Arbor lymphoma stage",
"description" : "The stage groups for lymphoma, defined using Ann Arbor staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-b-cell-agressive-nhl-cancer-type"
},
"name" : "NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type",
"description" : "The type of aggressive non-Hodgkin B cell lymphoma haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-b-cell-lymphoid-cancer-type"
},
"name" : "NZ cancer B cell lymphoid cancer type",
"description" : "The type of B cell lymphoid haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-b-cell-lymphoma-cancer-type"
},
"name" : "NZ cancer B cell lymphoma cancer type",
"description" : "The type of B cell lymphoma haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-basis-of-cancer-diagnosis"
},
"name" : "NZ cancer basis of diagnosis",
"description" : "Types of evidence that may be used to reach a cancer diagnosis.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-binet-cll-stage"
},
"name" : "NZ cancer Binet staging for CLL stage",
"description" : "The stage groups for chronic lymphocytic leukaemia, defined using Binet staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-bl-ipi-prognostic-score"
},
"name" : "NZ cancer BL-IPI prognostic score",
"description" : "The prognostic score for Burkitt lymphoma, defined using the Burkitt Lymphoma International Prognostic Index (BL-IPI) scoring system..",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-bone-cancer-type"
},
"name" : "NZ cancer bone cancer type",
"description" : "The type of the primary bone solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-bone-other-topography"
},
"name" : "NZ cancer bone other topography",
"description" : "The body location used to describe the point of origin for other bone cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-breast-nac-topography"
},
"name" : "NZ cancer breast nipple-areola complex topography",
"description" : "The body location used to describe the point of origin for nipple-areola complex breast cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-colorectal-topography-metastectomy"
},
"name" : "NZ cancer colorectal metastectomy topography",
"description" : "Body sites that are accessed by a surgeon during a colorectal metastectomy procedure",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-ngs-pcr"
},
"name" : "NZ cancer PCR OR NGS test method",
"description" : "Test method procedures used in laboratory studies.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-procedure-specimen-gi-colorectal"
},
"name" : "NZ cancer gastrointestinal colorectal specimen collection procedure ",
"description" : "Specimen collection procedures used in the diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-endo"
},
"name" : "NZ cancer gastrointestinal colorectal endoscopic resection specimen collection procedure ",
"description" : "Specimen collection endoscopic resection procedures used in the diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-met"
},
"name" : "NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure ",
"description" : "Specimen collection metastecomy resection procedures used in the diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-op"
},
"name" : "NZ cancer gastrointestinal colorectal operative resection specimen collection procedure ",
"description" : "Specimen collection operative resection procedures used in the diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-service"
},
"name" : "NZ cancer service",
"description" : "The type of cancer service that is currently, or should in the future, treat this cancer.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-stream"
},
"name" : "NZ cancer stream",
"description" : "The category of the primary cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-substream"
},
"name" : "NZ cancer substream",
"description" : "The subcategory of the primary cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-topography-colonoscopy"
},
"name" : "New Zealand cancer colorectal colonoscopy topography",
"description" : "Body sites that are accessed by a surgeon during a colonoscopy procedure or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cancer-type"
},
"name" : "NZ cancer type",
"description" : "The type of primary cancer being assessed.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-brain-topography"
},
"name" : "NZ cancer central nervous system brain topography",
"description" : "The body location used to describe the point of origin for brain cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-cancer-type"
},
"name" : "NZ cancer CNS cancer type",
"description" : "The type of the primary central nervous system (CNS) solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-ipi-prognostic-score"
},
"name" : "NZ cancer CNS-IPI for large B cell lymphoma prognostic score",
"description" : "The prognostic score for large B-cell lymphoma, defined using the Central Nervous System International Prognostic Index (CSN-IPI) scoring system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-meninges-topography"
},
"name" : "NZ cancer central nervous system meninges topography",
"description" : "The body location used to describe the point of origin for meninges cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-nerve-topography"
},
"name" : "NZ cancer central nervous system nerve topography",
"description" : "The body location used to describe the point of origin for nerve cancer of the central nervous system or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-other-topography"
},
"name" : "NZ cancer central nervous system other topography",
"description" : "The body location used to describe the point of origin for other central nervous system cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-spinal-cord-topography"
},
"name" : "NZ cancer central nervous system spinal cord topography",
"description" : "The body location used to describe the point of origin for spinal cord cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-status-prognostic-score"
},
"name" : "NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score",
"description" : "The prognostic score for reporting status in acute lymphoblastic lymphoma, defined using the central nervous system (CNS) prognostic scoring system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-cns-topography"
},
"name" : "NZ cancer central nervous system topography",
"description" : "The body location used to describe the point of origin for central nervous system cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-colorectal-cancer-type"
},
"name" : "NZ cancer colorectal cancer type",
"description" : "The type of the primary colorectal solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-colorectal-colon-perforation"
},
"name" : "NZ perforation present in colon ",
"description" : "Whether or not perforation of colon is or is not identified.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-completion-status"
},
"name" : "NZ cancer completion status",
"description" : "The completion status of the procedure and/or test.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-data-absent-reason"
},
"name" : "NZ cancer data absent reason",
"description" : "A reason that no specific value is available.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-detected-result"
},
"name" : "NZ cancer detected result",
"description" : "The result for a test (eg detected, not detected), where more specific finding values are not available.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-dipss-plus-prognostic-score"
},
"name" : "NZ cancer DIPSS+ for myelofibrosis prognostic score",
"description" : "The prognostic score for myelofibrosis, defined using the Dynamic International Prognostic Scoring System Plus (DIPSS+).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-ecog-status"
},
"name" : "NZ cancer ECOG status",
"description" : "The performance status of a patient as defined by the Eastern Cooperative Oncology Group (ECOG).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-eln-prognostic-score"
},
"name" : "NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score",
"description" : "The prognostic score for reporting genetic alteration in acute myeloid leukaemia, defined using the European LeukemiaNet (ELN) prognostic scoring system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-endocrine-cancer-type"
},
"name" : "NZ cancer endocrine cancer type",
"description" : "The type of the primary endocrine solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-leukaemia-substream"
},
"name" : "NZ cancer leukaemia substream",
"description" : "The subcategory of leukaemia haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphnode-breast"
},
"name" : "NZ cancer breast lymph node",
"description" : "Lymph nodes used for diagnosis of breast cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphnode-gastrointestinal-colorectal"
},
"name" : "NZ cancer gastrointestinal colorectal lymph node ",
"description" : "Lymph nodes used for diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphnode-gastrointestinal"
},
"name" : "NZ cancer gastrointestinal lymph node ",
"description" : "Lymph nodes used for diagnosis of gastrointestinal cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphnode-thorax-lung"
},
"name" : "NZ cancer thorax lung lymph node ",
"description" : "Lymph nodes used for diagnosis of thoracic lung cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphnode-thorax"
},
"name" : "NZ cancer thorax lymph node ",
"description" : "Lymph nodes used for diagnosis of thoracic cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphnode"
},
"name" : "NZ cancer lymph node ",
"description" : "Lymph nodes used for diagnosis of cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphoma-cancer-type"
},
"name" : "NZ cancer lymphoma cancer type",
"description" : "The type of lymphoma haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-lymphoma-substream"
},
"name" : "NZ cancer lymphoma substream",
"description" : "The subcategory of lymphoma haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-male-genital-other-topography"
},
"name" : "NZ cancer male genital other topography",
"description" : "The body location used to describe the point of origin for other male genital cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-male-genital-sact-cancer-type"
},
"name" : "NZ cancer male genital SACT cancer type",
"description" : "The type of the primary male genital solid cancer being assessed and treated, by systemic anti-cancer therapy (SACT).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-male-genital-topography"
},
"name" : "NZ cancer male genital topography",
"description" : "The body location used to describe the point of original for male genital cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-mastocytosis-cancer-type"
},
"name" : "NZ cancer mastocytosis cancer type",
"description" : "The type of mastocytosis haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-mature-t-nk-cell-lymphoid-cancer-type"
},
"name" : "NZ cancer mature T/NK cell lymphoid cancer type",
"description" : "The type of mature T-cell and/or natural killer cell neoplasm cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-mayo-amyloidosis-stage"
},
"name" : "NZ cancer Mayo staging for AL (amyloidosis) stage",
"description" : "The stage groups for amyloidosis, defined using Mayo staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-md-anderson-residual-cancer-burden"
},
"name" : "NZ cancer MD Anderson residual cancer burden",
"description" : "The neoadjuvant therapy response score for breast, defined using the MD Anderson residual cancer burden system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-mds-myeloproliferative-cancer-type"
},
"name" : "NZ cancer myelodysplastic-myeloproliferative cancer type",
"description" : "The type of myelodysplastic-myeloproliferative haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-melanoma-cancer-type"
},
"name" : "NZ cancer melanoma cancer type",
"description" : "The type of the primary melanoma solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-midline-topography"
},
"name" : "NZ cancer midline topography",
"description" : "A body structure where cancer may be present, which is symmetrical on the body's midline or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-mipi-prognostic-score"
},
"name" : "NZ cancer MIPI prognostic score",
"description" : "The prognostic score for mantle cell lymphoma, defined using the Mantle Cell Lymphoma International Prognostic Scoring (MIPI) system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-mo-treatment-intent"
},
"name" : "NZ cancer medical oncology treatment intent",
"description" : "Intents or reasons for using a therapeutic procedure to treat solid tumours.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-modified-ryan-score"
},
"name" : "NZ cancer modified Ryan tumour regression score",
"description" : "The neoadjuvant therapy response score for tumours, defined using the modified Ryan tumour regression score plus not administered value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-moh-refcrit-colonoscopy-2w"
},
"name" : "New Zealand cancer colorectal colonoscopy 2 week referral criteria",
"description" : "The 2 week referral criteria published by the Ministry of Health for outpatient colonoscopies.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-moh-refcrit-colonoscopy-6w"
},
"name" : "New Zealand cancer colorectal colonoscopy 6 week referral criteria",
"description" : "The 6 week referral criteria published by the Ministry of Health for outpatient colonoscopies.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-myeloid-cancer-type"
},
"name" : "NZ cancer myeloid proliferation and/or myeloid neoplasm cancer type",
"description" : "The type of myeloid proliferation and/or myeloid neoplasm haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-myeloproliferative-cancer-type"
},
"name" : "NZ cancer myeloproliferative cancer type",
"description" : "The type of myeloproliferative haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-nasal-paranasal-cancer-type"
},
"name" : "NZ cancer nasal cavity and paranasal sinus cancer type",
"description" : "The type of the primary nasal cavity and paranasal sinus solid cancer being assessed and treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-neoadjuvant-therapy-response-system"
},
"name" : "NZ cancer neoadjuvant therapy response system",
"description" : "A scoring system system used to measure a patient's response to neoadjuvant therapy.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-neoadjuvant-therapy-type"
},
"name" : "NZ cancer neoadjuvant therapy administration type",
"description" : "The type of neoadjuvant therapy that has been performed or an 'Unknown' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-neuroendocrine-cancer-type"
},
"name" : "NZ cancer neuroendocrine cancer type",
"description" : "The type of the primary neuroendocrine solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-neuroendocrine-gep-cancer-type"
},
"name" : "NZ cancer neuroendocrine GEP cancer type",
"description" : "The type of the primary neuroendocrine tumour gastroenteropancreatic (GEP) solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-neuroendocrine-non-gep-cancer-type"
},
"name" : "NZ cancer neuroendocrine non GEP cancer type",
"description" : "The type of the primary neuroendocrine tumour non-gastroenteropancreatic (non-GEP) solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-neuroendocrine-substream"
},
"name" : "NZ cancer neuroendocrine substream",
"description" : "The subcategory of the primary neuroendocrine solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-nk-t-cell-nhl-stage"
},
"name" : "NZ cancer NK/T cell non Hodgkin lymphoma treatment stratification stage",
"description" : "The stage groups for NK-cell and/or T-cell lymphoma, defined using non-Hodgkin lymphoma treatment stratification staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-non-hodgkin-lymphoma-cancer-type"
},
"name" : "NZ cancer non Hodgkin lymphoma cancer type",
"description" : "The type of non Hodgkin lymphoma haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-non-prostate-genitourinary-cancer-type"
},
"name" : "NZ cancer genitourinary (non prostate) cancer type",
"description" : "The type of primary non prostate genitourinary solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-not-performed-reason"
},
"name" : "NZ cancer not performed reason",
"description" : "The reason why the procedure and/or test was not performed.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-nottingham-grade"
},
"name" : "NZ Nottingham Combined grade",
"description" : "The grade of a breast cancer, assessed using the Nottingham combined grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-nuclear-grade"
},
"name" : "NZ cancer nuclear grade of DCIS grade",
"description" : "The grade of a breast cancer, assessed using the nuclear ductal carcinoma in situ grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-observation"
},
"name" : "NZ cancer observation code",
"description" : "Observable entities used to represent the meaning of CanShare data elements.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-orbit-topography"
},
"name" : "NZ cancer orbit topography",
"description" : "The body location used to describe the point of origin for orbit cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-performance-status"
},
"name" : "NZ cancer performance status",
"description" : "The performance status of the procedure and/or test.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-pharynx-larynx-cancer-type"
},
"name" : "NZ cancer pharynx and larynx and trachea cancer type",
"description" : "The type of the primary pharynx and/or larynx and/or trachea solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-pit-prognostic-score"
},
"name" : "NZ cancer PIT prognostic score",
"description" : "The prognostic score for T-cell lymphoma, defined using the Prognostic Index for T-cell Lymphoma (PIT) prognostic scoring system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-plasma-cell-cancer-type"
},
"name" : "NZ cancer plasma cell cancer type",
"description" : "The type of plasma cell haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-pr-expression"
},
"name" : "NZ cancer PR expression",
"description" : "An assessment of whether or not a tumour is progesterone receptive (PR).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-presence-tumour-finding"
},
"name" : "NZ cancer presence of tumour finding ",
"description" : "Presence of tumour findings in relation to prognostic factors of a cancer diagnosis.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-primary-topography"
},
"name" : "NZ cancer primary topography",
"description" : "A body location used to describe the point of origin for a cancer type, or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-procedure"
},
"name" : "NZ cancer procedure",
"description" : "An activity involved in the performance of healthcare",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-prognostic-scoring-system"
},
"name" : "NZ cancer prognostic scoring system",
"description" : "Systems that may be used to score the prognostic factors of a cancer diagnosis or an \"other value\"",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-rai-cll-stage"
},
"name" : "NZ cancer Rai staging for CLL stage",
"description" : "The stage groups for chronic lymphocytic leukaemia, defined by Rai staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-recurrence-type"
},
"name" : "NZ cancer recurrence type",
"description" : "The type of cancer recurrence, e.g. local, regional plus unknown and not applicable values.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-referral-pathway-simple"
},
"name" : "NZ cancer referral pathway simple",
"description" : "The simple cancer pathway by which the patient was referred for the given service ie screening or diagnostic.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-revised-multiple-myeloma-stage"
},
"name" : "NZ cancer R-ISS for multiple myeloma stage",
"description" : "The stage groups for multiple myeloma, defined using Revised International Staging System (R-ISS).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-all-disease-response"
},
"name" : "NZ SACT acute lymphoblastic leukemia disease response",
"description" : "Types of responses to an acute lymphoblastic leukaemia systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-aml-disease-response"
},
"name" : "NZ SACT acute myeloid leukemia disease response",
"description" : "Types of responses to an acute myeloid leukaemia systemic anti-cancer therapy (SACT) treament.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-amyloidosis-disease-response"
},
"name" : "NZ SACT amyloidosis disease response",
"description" : "Types of responses to an amyloidosis systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-basis-of-cancer-diagnosis"
},
"name" : "NZ SACT basis of diagnosis",
"description" : "Types of evidence that may be used to reach a cancer diagnosis, which is treated with systemic anti cancer therapy (SACT).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-cancer-type"
},
"name" : "NZ SACT cancer type",
"description" : "The type of primary cancer being assessed, by systemic anti-cancer therapy (SACT).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-cll-sll-disease-response"
},
"name" : "NZ SACT chronic lymphocytic leukemia and/or small lymphocytic lymphoma disease response",
"description" : "Types of responses to a chronic lymphocytic leukaemia and/or small lymphocytic lymphoma systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-cml-disease-response"
},
"name" : "NZ SACT chronic myeloid leukemia disease response",
"description" : "Types of responses to a chronic myeloid leukaemia systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-dose-adjustment-reason"
},
"name" : "NZ SACT dose adjustment reason",
"description" : "Reasons for adjusting the dose of a systemic anti-cancer therapy (SACT) treatment cycle plus other value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-dose-form"
},
"name" : "NZ SACT dose form",
"description" : "Dose forms in which a systemic anti-cancer therapy (SACT) medication may be prescribed or administered.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-dose-unit"
},
"name" : "NZ SACT dose unit",
"description" : "Units that may be used to describe the dose of a systemic anti-cancer therapy (SACT) medication.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-er-expression"
},
"name" : "NZ SACT ER expression",
"description" : "A diagnosis of whether or not a tumour is estrogen receptive (ER) minus inconculsive value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-her2-expression"
},
"name" : "NZ SACT HER2 expression",
"description" : "A diagnosis of the human epidermal growth factor receptor 2 (HER2) status of a tumour minus inconculsive value .",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-mds-disease-response"
},
"name" : "NZ SACT myelodysplastic syndrome disease response",
"description" : "Types of responses to a myelodysplastic syndrome systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-mo-disease-response"
},
"name" : "NZ SACT medical oncology disease response",
"description" : "Types of responses to a medical oncology systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-myeloma-disease-response"
},
"name" : "NZ SACT myleoma disease response",
"description" : "Types of responses to a myeloma systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-non-small-lymphocytic-disease-response"
},
"name" : "NZ SACT lymphoma (non small lymphocytic) disease response",
"description" : "Types of responses to a non small lymphocytic systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-overall-discontinue-reason"
},
"name" : "NZ SACT overall discontinue reason",
"description" : "Overall reasons that a systemic anti-cancer therapy (SACT) regimen may be discontinued plus other value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-patient-factor-discontinue-reason"
},
"name" : "NZ SACT patient factor discontinue",
"description" : "Patient factors that may result in the discontinuation of a systemic anti-cancer therapy (SACT) treatment plus not asked value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-pr-expression"
},
"name" : "NZ SACT PR expression",
"description" : "A diagnosis of whether or not a tumour is progesterone receptive (PR) minus inconculsive value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-regimen-code"
},
"name" : "NZ SACT regimen code",
"description" : "Systemic anti-cancer therapy (SACT) regimens published by the New Zealand Medicines Formulary in the SACT Regimen Library.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-route-of-administration"
},
"name" : "NZ SACT route of administration",
"description" : "Routes by which a systemic anti-cancer therapy (SACT) medication may be administered to a patient.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sact-toxicity-discontinue-reason"
},
"name" : "NZ systemic anti-cancer therapy toxicity discontinue reason",
"description" : "Toxicity factors that may result in the discontinuation of a systemic anti-cancer therapy (SACT) treatment.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-side-mandatory"
},
"name" : "NZ cancer side mandatory",
"description" : "The side of a body structure that is symmetrical to the midline, e.g. left side, right side, both sides, central, or a 'definitely not present' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-side-optional"
},
"name" : "NZ cancer side optional",
"description" : "The side of a body structure that is symmetrical to the midline, e.g. left side, right side, both sides, central, or a 'unknown' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-skin-cancer-type"
},
"name" : "NZ cancer skin cancer type",
"description" : "The type of the primary skin solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-skin-melanoma-cancer-type"
},
"name" : "NZ cancer skin and/or melanoma cancer type",
"description" : "The type of the primary skin and/or melanoma solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-skin-melanoma-substream"
},
"name" : "NZ cancer skin and/or melanoma substream",
"description" : "The subcategory of the primary skin and/or melanoma solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-skin-topography"
},
"name" : "NZ cancer skin topography",
"description" : "The body location used to describe the point of origin for skin cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-soft-tissue-bone-cancer-type"
},
"name" : "NZ cancer soft tissue and/or bone cancer type",
"description" : "The type of the primary soft tissue and/or bone solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-soft-tissue-bone-substream"
},
"name" : "NZ cancer soft tissue and/or bone substream",
"description" : "The subcategory of the primary soft tissue and/or bone solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-soft-tissue-cancer-type"
},
"name" : "NZ cancer soft tissue cancer type",
"description" : "The type of the primary soft tissue solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-sokal-prognostic-score"
},
"name" : "NZ cancer Sokal index for CML prognostic score",
"description" : "The prognostic score for chronic myeloid leukaemia, defined using the Sokal index prognostic scoring system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-solid-cancer-stream"
},
"name" : "NZ cancer solid tumour stream",
"description" : "The category of the primary solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-solid-tumour-grading-system"
},
"name" : "NZ cancer solid tumour grading system",
"description" : "Grading systems used to assess the grade of a solid tumour.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-solid-tumour-sact-cancer-type"
},
"name" : "NZ cancer solid tumour SACT cancer type",
"description" : "The type of the primary solid cancer being assessed and treated, by systemic anti-cancer therapy (SACT).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-solid-tumour-staging-system"
},
"name" : "NZ cancer solid tumour staging system",
"description" : "Systems that may be used to classify the stage of a solid tumour or an \"other value\"",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-solid-tumour-substream"
},
"name" : "NZ cancer solid tumour substream",
"description" : "The subcategory of the primary solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-spread-type"
},
"name" : "NZ cancer spread type",
"description" : "The type of cancer spread eg. local invasion, distant metastasis plus unknown and not applicable values.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-staging-system"
},
"name" : "NZ cancer staging system",
"description" : "Systems that may be used to classify the stage of a cancer diagnosis or an \"other value\"",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-t-nk-cell-lymphoid-cancer-type"
},
"name" : "NZ cancer T/NK cell lymphoid cancer type",
"description" : "The type of T/ NK cell lymphoid haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-t-nk-cell-lymphoma-cancer-type"
},
"name" : "NZ cancer T/NK cell lymphoma cancer type",
"description" : "The type of T/NK cell lymphoma haematologic cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-test-failure-reason"
},
"name" : "NZ cancer test failure reason",
"description" : "The reason why the test failed.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-test-inconclusive-reason"
},
"name" : "NZ cancer test inconclusive reason",
"description" : "The reason why the test result is inconclusive.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/canshare-test-nonsnomed"
},
"name" : "canshare-test-nonsnomed",
"description" : "canshare-test-nonsnomed",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/canshare-test-ns1"
},
"name" : "Canshare testing non-snomed concepts",
"description" : "Canshare testing non-snomed concepts",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thoracic-cancer-type"
},
"name" : "NZ cancer thoracic cancer type",
"description" : "The type of the primary thoracic solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thorax-lung-topography"
},
"name" : "NZ cancer thorax lung topography",
"description" : "The body location used to describe the point of origin for lung cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thorax-pericardium-topography"
},
"name" : "NZ cancer thorax pericardium topography",
"description" : "The body location used to describe the point of origin for pericardium cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thorax-pleura-topography"
},
"name" : "NZ cancer thorax pleura topography",
"description" : "The body location used to describe the point of origin for pleura cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thorax-soft-tissue-topography"
},
"name" : "NZ cancer thorax soft tissue topography",
"description" : "The body location used to describe the point of origin for soft tissue sarcoma of thorax and/or mediastinum primary or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thorax-thymus-topography"
},
"name" : "NZ cancer thorax thymus topography",
"description" : "The body location used to describe the point of origin for thymus cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-thorax-topography"
},
"name" : "NZ cancer thorax topography",
"description" : "The body location used to describe the point of origin for thorax cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-b-lymphoma-stage"
},
"name" : "NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage",
"description" : "The revised stage groups for primary cutaneous T-cell lymphoma, defined using TNM-B category staging system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-breast-cm"
},
"name" : "NZ AJCC breast clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a breast tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-breast-ct"
},
"name" : "NZ AJCC breast clinical T category",
"description" : "A clinical tumour stage (cT) of a breast tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-breast-pn"
},
"name" : "NZ AJCC breast pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a breast tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-breast-pt"
},
"name" : "NZ AJCC breast pathological T category",
"description" : "A pathological tumour stage (pT) of a breast tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-breast-stage-group"
},
"name" : "NZ AJCC breast stage group",
"description" : "The anatomic and prognostic stage groups that describe how far a breast cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-clinical-stage-group"
},
"name" : "NZ AJCC clinical stage group",
"description" : "The clinical stage groups that describe how far a cancer has grown and spread before initiation of treatment, using AJCC cancer staging manual.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-cm"
},
"name" : "NZ AJCC clinical M category",
"description" : "A clinical distant metastasis stage (cM) before initiation of treatment, using the AJCC cancer staging manual.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-cn"
},
"name" : "NZ AJCC clinical N category",
"description" : "A clinical regional lymph node stage (cN) before initiation of treatment, using the AJCC cancer staging manual.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-ct"
},
"name" : "NZ AJCC clinical T category",
"description" : "A clinical tumour stage (cT) of a tumour before initiation of treatment, using the AJCC cancer staging manual.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-gen-corpus-uteri-adenosarcoma-stage-group"
},
"name" : "NZ AJCC female genital corpus uteri adenosarcoma stage group",
"description" : "The stage group that describe how far a corpus uteri adenosarcoma has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-gen-ovary-fallopian-peritoneal-stage-group"
},
"name" : "NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma stage group",
"description" : "The stage group that describe how far a ovary, fallopian tube and/or peritoneal carcinoma has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-cm"
},
"name" : "NZ AJCC female genital cervix uteri clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-cn"
},
"name" : "NZ AJCC female genital cervix uteri clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-ct"
},
"name" : "NZ AJCC female genital cervix uteri clinical T category",
"description" : "A clinical tumour stage (cT) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-pm"
},
"name" : "NZ AJCC female genital cervix uteri pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a cervix uteri tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-pn"
},
"name" : "NZ AJCC female genital cervix uteri pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a cervix uteri tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-pt"
},
"name" : "NZ AJCC female genital cervix uteri pathological T category",
"description" : "A pathological tumour stage (pT) of a cervix uteri tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group"
},
"name" : "NZ AJCC female genital cervix uteri stage group",
"description" : "The stage group that describe how far a cervix uteri cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cm"
},
"name" : "NZ AJCC female genital clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-cn"
},
"name" : "NZ AJCC female genital clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-ct"
},
"name" : "NZ AJCC female genital corpus uteri adenosarcoma clinical T category",
"description" : "A clinical tumour stage (cT) of a corpus uteri adenosarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pn"
},
"name" : "NZ AJCC female genital corpus uteri adenosarcoma pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a corpus uteri adenosarcoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn"
},
"name" : "NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a corpus uteri carcinoma and/or carcinosarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct"
},
"name" : "NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma clinical T category",
"description" : "A clinical tumour stage (cT) of a corpus uteri carcinoma and/or carcinosarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pn"
},
"name" : "NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a corpus uteri carcinoma and/or carcinosarcoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt"
},
"name" : "NZ AJCC female genital corpus uteri carcinoma and/or carcinosarcoma pathological T category",
"description" : "A pathological tumour stage (pT) of a corpus uteri carcinoma and/or carcinosarcoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-cm"
},
"name" : "NZ AJCC female genital corpus uteri clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a corpus uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-cn"
},
"name" : "NZ AJCC female genital corpus uteri clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a corpus uteri before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-ct"
},
"name" : "NZ AJCC female genital corpus uteri clinical T category",
"description" : "A clinical tumour stage (cT) of a corpus uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn"
},
"name" : "NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a corpus uteri leimyosarcoma and/or endometrial stromal sarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct"
},
"name" : "NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma clinical T category",
"description" : "A clinical tumour stage (cT) of a corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pn"
},
"name" : "NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt"
},
"name" : "NZ AJCC female genital corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma pathological T category",
"description" : "A pathological tumour stage (pT) of a corpus uteri leiomyosarcoma and/or endometrial stromal sarcoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-pm"
},
"name" : "NZ AJCC female genital corpus uteri pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a corpus uteri tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-pn"
},
"name" : "NZ AJCC female genital corpus uteri pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a corpus uteri tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-pt"
},
"name" : "NZ AJCC female genital corpus uteri pathological T category",
"description" : "A pathological tumour stage (pT) of a corpus uteri tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group"
},
"name" : "NZ AJCC female genital corpus uteri stage group",
"description" : "The stage group that describe how far a corpus uteri cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-gestational-cm"
},
"name" : "NZ AJCC female genital gestational trophoblastic disease clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a gestational trophoblastic tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-gestational-ct"
},
"name" : "NZ AJCC female genital gestational trophoblastic disease clinical T category",
"description" : "A clinical tumour stage (cT) of a gestational trophoblastic tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-gestational-pm"
},
"name" : "NZ AJCC female genital gestational trophoblastic disease pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a gestational trophoblastic tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-gestational-pt"
},
"name" : "NZ AJCC female genital gestational trophoblastic disease pathological T category",
"description" : "A pathological tumour stage (pT) of a gestational trophoblastic tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-gestational-stage-group"
},
"name" : "NZ AJCC female genital gestational trophoblastic disease stage group",
"description" : "The stage group that describe how far a gestational trophoblastic cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm"
},
"name" : "NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a ovary, fallopian tube and/or primary peritoneal carcinoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-ct"
},
"name" : "NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma clinical T category",
"description" : "A clinical tumour stage (cT) of a ovary, fallopian tube and/or peritoneal carcinoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pm"
},
"name" : "NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a ovary, fallopian tube and/or primary peritoneal carcinoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pn"
},
"name" : "NZ AJCC female genital ovary and/or fallopian tube and/or primary peritoneal carcinoma pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a ovary, falliopian and/or primary peritoneal carcinoma, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-pn"
},
"name" : "NZ AJCC female genital pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a female genital tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-pt"
},
"name" : "NZ AJCC female genital pathological T category",
"description" : "A pathological tumour stage (pT) of a female genital tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-stage-group"
},
"name" : "NZ AJCC female genital stage group",
"description" : "The stage groups that describe how far a female genital cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vagina-cm"
},
"name" : "NZ AJCC female genital vagina clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a vagina tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vagina-cn"
},
"name" : "NZ AJCC female genital vagina clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a vagina tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vagina-ct"
},
"name" : "NZ AJCC female genital vagina clinical T category",
"description" : "A clinical tumour stage (cT) of a vagina tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vagina-pm"
},
"name" : "NZ AJCC female genital vagina pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a vagina tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vagina-pn"
},
"name" : "NZ AJCC female genital vagina pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a vagina tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vagina-pt"
},
"name" : "NZ AJCC female genital vagina pathological T category",
"description" : "A pathological tumour stage (pT) of a vagina tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-cm"
},
"name" : "NZ AJCC female genital vulva clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-cn"
},
"name" : "NZ AJCC female genital vulva clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-ct"
},
"name" : "NZ AJCC female genital vulva clinical T category",
"description" : "A clinical tumour stage (cT) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-pm"
},
"name" : "NZ AJCC female genital vulva pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a vulva tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-pn"
},
"name" : "NZ AJCC female genital vulva pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a vulva tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-pt"
},
"name" : "NZ AJCC female genital vulva pathological T category",
"description" : "A pathological tumour stage (pT) of a vulva tumour, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-female-genital-vulva-stage-group"
},
"name" : "NZ AJCC female genital vulva stage group",
"description" : "The stage group that describe how far a vulva cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-cm"
},
"name" : "NZ AJCC gastrointestinal clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-cm"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a gastrointestional colon and/or rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-cn"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a gastrointestional colon and/or rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-ct"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum clinical T category",
"description" : "A clinical tumour stage (cT) of a gastrointestional colon and/or rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-pm"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a gastrointestional colon and/or rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-pn"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a gastrointestional colon and/or rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-pt"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum pathological T category",
"description" : "A pathological tumour stage (pT) of a gastrointestional colon and/or rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-colorectal-stage-group"
},
"name" : "NZ AJCC gastrointestinal colon and/or rectum stage group",
"description" : "The stage groups that describe how far a gastrointestinal colon and/or rectum cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-ct"
},
"name" : "NZ AJCC gastrointestinal clinical T category",
"description" : "A clinical tumour stage (cT) of a gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-pathological-stage-group"
},
"name" : "NZ AJCC gastrointestinal pathological stage group",
"description" : "The pathogical stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-pm"
},
"name" : "NZ AJCC gastrointestinal pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-pt"
},
"name" : "NZ AJCC gastrointestinal pathological T category",
"description" : "A pathological tumour stage (pT) of a gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gi-yp-stage-group"
},
"name" : "NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group",
"description" : "A post therapy or post neoadjuvant therapy pathological tumour stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-cm"
},
"name" : "NZ AJCC gastrointestinal stromal tumour clinical M category ",
"description" : "A clinical distant metastasis stage (cM) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-ct"
},
"name" : "NZ AJCC gastrointestinal stromal tumour clinical T category",
"description" : "A clinical tumour stage (cT) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-gastric-omental-stage-group"
},
"name" : "NZ AJCC gastrointestinal stromal tumour gastric and/or omental stage group",
"description" : "The stage groups that describe how far a gastrointestinal stromal tumour (GIST) gastric and/or omental has grown and spread, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-other-stage-group"
},
"name" : "NZ AJCC gastrointestinal stromal tumour small intestine and/or oesophageal and/or colon and/or rectum and/or mesenteric and/or peritoneal stage group ",
"description" : "The stage groups that describe how far a gastrointestinal stromal tumour (GIST) small intestine and/or oesophageal and/or colon and/or rectum and/or mesenteric and/or peritoneal has grown and spread, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-pm"
},
"name" : "NZ AJCC gastrointestinal stromal tumour pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-pn"
},
"name" : "NZ AJCC gastrointestinal stromal tumour pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-gist-pt"
},
"name" : "NZ AJCC gastrointestinal stromal tumour pathological T category",
"description" : "A pathological tumour stage (pT) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-haematology-cll-or-sll-stage-group"
},
"name" : "NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group",
"description" : "The stage groups that describe how far a chronic lymphocytic lymphoma or a small lymphocytic lymphoma has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-haematology-cm"
},
"name" : "NZ AJCC haematology clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-haematology-cn"
},
"name" : "NZ AJCC haematology clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-haematology-ct"
},
"name" : "NZ AJCC haematology clinical T category",
"description" : "A clinical tumour stage (cT) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-haematology-hl-or-nhl-stage-group"
},
"name" : "NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group",
"description" : "The stage groups that describe how far a Hodgkin or non-Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm-haematology-mf-or-ss-cm"
},
"name" : "NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-i "exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gi-yp-stage-group"
},
"name" : "NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group",
"description" : "A post therapy or post neoadjuvant therapy pathological tumour stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-cm"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-cn"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-ct"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category",
"description" : "A clinical tumour stage (cT) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-gastric-omental-stage-group"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour gastric and/or omental stage group",
"description" : "The stage groups that describe how far a gastrointestinal stromal tumour (GIST) gastric and/or omental has grown and spread, using chapter 43.1 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-other-stage-group"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour small intestine and/or oesophageal and/or colon and/or rectum and/or mesenteric and/or peritoneal stage group",
"description" : "The stage groups that describe how far a gastrointestinal stromal tumour (GIST) small intestine and/or oesophageal and/or colon and/or rectum and/or mesenteric and/or peritoneal has grown and spread, using chapter 43.1 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-pn"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-gist-pt"
},
"name" : "NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category",
"description" : "A pathological tumour stage (pT) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-cll-or-sll-stage-group"
},
"name" : "NZ AJCC (8th edition) haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group",
"description" : "The stage groups that describe how far a chronic lymphocytic lymphoma or a small lymphocytic lymphoma has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-cm"
},
"name" : "NZ AJCC (8th edition) haematology clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-cn"
},
"name" : "NZ AJCC (8th edition) haematology clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-ct"
},
"name" : "NZ AJCC (8th edition) haematology clinical T category",
"description" : "A clinical tumour stage (cT) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-hl-or-nhl-stage-group"
},
"name" : "NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group",
"description" : "The stage groups that describe how far a Hodgkin or non Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-mf-or-ss-cm"
},
"name" : "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-mf-or-ss-cn"
},
"name" : "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-mf-or-ss-ct"
},
"name" : "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category",
"description" : "A clinical tumour stage (cT) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-mf-or-ss-pn"
},
"name" : "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-mf-or-ss-pt"
},
"name" : "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category",
"description" : "A pathological tumour stage (pT) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-mf-or-ss-stage-group"
},
"name" : "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome stage group",
"description" : "The stage groups that describe how far a mycosis fungoides or sezary syndrome has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-cm"
},
"name" : "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome) before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-ct"
},
"name" : "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category",
"description" : "A clinical tumour stage (cT) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome) before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pm"
},
"name" : "NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome), using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pn"
},
"name" : "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome), using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pt"
},
"name" : "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category",
"description" : "A pathological tumour stage (pT) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome), using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-paed-hl-stage-group"
},
"name" : "NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group",
"description" : "The stage groups that describe how far a paediatric Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-paed-nhl-stage-group"
},
"name" : "NZ AJCC (8th edition) haematology pediatric non Hodgkin lymphoma stage group",
"description" : "The stage groups that describe how far a paediatric non Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-pm"
},
"name" : "NZ AJCC (8th edition) haematology pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a haematologic cancer, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-pn"
},
"name" : "NZ AJCC (8th edition) haematology pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a haematologic cancer, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-haematology-pt"
},
"name" : "NZ AJCC (8th edition) haematology pathological T category",
"description" : "A pathological tumour stage (pT) of a haematologic cancer, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-cm"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-cn"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cm"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a neuroendocrine gastrointestinal colon and/or rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cn"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a neuroendocrine gastrointestinal colon and/or rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-ct"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum clinical T category",
"description" : "A clinical tumour stage (cT) of a neuroendocrine gastrointestinal colon and/or rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pm"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a neuroendocrine gastrointestinal colon and/or rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pn"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a neuroendocrine gastrointestinal colon and/or rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pt"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum pathological T category",
"description" : "A pathological tumour stage (pT) of a neuroendocrine gastrointestinal colon and/or rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-stage-group"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and/or rectum stage group",
"description" : "The stage groups that describe how far a neuroendocrine gastrointestinal colon and/or rectum cancer has grown and spread, using chapter 33 of the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-ct"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical T category",
"description" : "A clinical tumour stage (cT) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-pm"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-pn"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-pt"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category",
"description" : "A pathological tumour stage (pT) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-neuroendocrine-gi-stage-group"
},
"name" : "NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group",
"description" : "The stage groups that describe how far a neuroendocrine gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-cm"
},
"name" : "NZ AJCC (8th edition) thoracic clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a thoracic tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-cn"
},
"name" : "NZ AJCC (8th edition) thoracic clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a thoracic tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-ct"
},
"name" : "NZ AJCC (8th edition) thoracic clinical T category",
"description" : "A clinical tumour stage (cT) of a thoracic tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-lung-cm"
},
"name" : "NZ AJCC (8th edition) thoracic lung clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a lung tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-lung-cn"
},
"name" : "NZ AJCC (8th edition) thoracic lung clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a lung tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-lung-ct"
},
"name" : "NZ AJCC (8th edition) thoracic lung clinical T category",
"description" : "A clinical tumour stage (cT) of a lung tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-lung-pm"
},
"name" : "NZ AJCC (8th edition) thoracic lung pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a lung tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-lung-pt"
},
"name" : "NZ AJCC (8th edition) thoracic lung pathological T category",
"description" : "A pathological tumour stage (pT) of a lung tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-lung-stage-group"
},
"name" : "NZ AJCC (8th edition) thoracic lung stage group",
"description" : "The stage groups that describe how far a lung cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pleural-cm"
},
"name" : "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a malignant pleural mesothelioma tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pleural-cn"
},
"name" : "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a malignant pleural mesothelioma tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pleural-pm"
},
"name" : "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a malignant pleural mesothelioma tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pleural-pt"
},
"name" : "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological T category",
"description" : "A pathological tumour stage (pT) of a malignant pleural mesothelioma tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pm"
},
"name" : "NZ AJCC (8th edition) thoracic pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a thoracic tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pn"
},
"name" : "NZ AJCC (8th edition) thoracic pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a thoracic tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-pt"
},
"name" : "NZ AJCC (8th edition) thoracic pathological T category",
"description" : "A pathological tumour stage (pT) of a thoracic tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-stage-group"
},
"name" : "NZ AJCC (8th edition) thoracic stage group",
"description" : "The stage groups that describe how far a thoracic cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-cm"
},
"name" : "NZ AJCC (8th edition) thoracic thymus clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-cn"
},
"name" : "NZ AJCC (8th edition) thoracic thymus clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-ct"
},
"name" : "NZ AJCC (8th edition) thoracic thymus clinical T category",
"description" : "A clinical tumour stage (cT) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-pm"
},
"name" : "NZ AJCC (8th edition) thoracic thymus pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a thymus tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-pn"
},
"name" : "NZ AJCC (8th edition) thoracic thymus pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a thymus tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-pt"
},
"name" : "NZ AJCC (8th edition) thoracic thymus pathological T category",
"description" : "A pathological tumour stage (pT) of a thymus tumour, using the AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm8-thoracic-thymus-stage-group"
},
"name" : "NZ AJCC (8th edition) thoracic thymus stage group",
"description" : "The stage group that describe how far a thymus cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-cm"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-cn"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-ct"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri clinical T category",
"description" : "A clinical tumour stage (cT) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-pm"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a cervix uteri tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-pn"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a cervix uteri tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-pt"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri pathological T category",
"description" : "A pathological tumour stage (pT) of a cervix uteri tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cervix-uteri-stage-group"
},
"name" : "NZ AJCC (9th edition) female genital cervix uteri stage group",
"description" : "The stage group that describe how far a cervix uteri cancer has grown and spread, using AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cm"
},
"name" : "NZ AJCC (9th edition) female genital clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-cn"
},
"name" : "NZ AJCC (9th edition) female genital clinical N category",
"description" : "A clinical regional lymph node stage (cN) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-ct"
},
"name" : "NZ AJCC (9th edition) female genital clinical T category",
"description" : "A clinical tumour stage (cT) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-pm"
},
"name" : "NZ AJCC (9th edition) female genital pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a female genital tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-pn"
},
"name" : "NZ AJCC (9th edition) female genital pathological N category",
"description" : "A pathological regional lymph node stage (pN) of a female genital tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-pt"
},
"name" : "NZ AJCC (9th edition) female genital pathological T category",
"description" : "A pathological tumour stage (pT) of a female genital tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-stage-group"
},
"name" : "NZ AJCC (9th edition) female genital stage group",
"description" : "The stage groups that describe how far a female genital cancer has grown and spread, using AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-vulva-cm"
},
"name" : "NZ AJCC (9th edition) female genital vulva clinical M category",
"description" : "A clinical distant metastasis stage (cM) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tnm9-female-genital-vulva-pm"
},
"name" : "NZ AJCC (9th edition) female genital vulva pathological M category",
"description" : "A pathological distant metastasis stage (pM) of a vulva tumour, using the AJCC cancer staging manual (9th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-topography"
},
"name" : "NZ cancer topography",
"description" : "A body location used to describe the point of origin for a cancer type, a specimen, a procedure location, or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-treatment-intent"
},
"name" : "NZ cancer treatment intent",
"description" : "Treatment intents or reasons for using a therapeutic procedure to treat cancer.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-tumour-origin"
},
"name" : "NZ cancer tumour origin",
"description" : "The suspected origin of the tumour clinically assessed.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-unknown-site-topography"
},
"name" : "NZ cancer unknown site topography",
"description" : "The unknown body location of a cancer.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/canshare-unpublished-concepts"
},
"name" : "Concepts that are not yet formally published",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-upper-gastro-cancer-type"
},
"name" : "NZ cancer upper gastrointestinal cancer type",
"description" : "The type of the primary upper gastrointestinal solid cancer being assessed and/or treated.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-kidney-topography"
},
"name" : "NZ cancer urinary and/or male genital kidney topography",
"description" : "The body location used to describe the point of origin for kidney cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-penis-topography"
},
"name" : "NZ cancer urinary and/or male genital penis topography",
"description" : "The body location used to describe the point of origin for penis cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-prostate-topography"
},
"name" : "NZ cancer urinary and/or male genital prostate topography",
"description" : "The body location used to describe the point of origin for prostate cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-renal-pelvis-ureter-topography"
},
"name" : "NZ cancer urinary and/or male genital renal pelvis and/or ureter topography",
"description" : "The body location used to describe the point of origin for renal pelvis and ureter cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-testicular-adnexa-topography"
},
"name" : "NZ cancer urinary and/or male genital testicular adnexa topography",
"description" : "The body location used to describe the point of origin for testicular adnexa cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-testicular-sact-topography"
},
"name" : "NZ cancer urinary and male genital testicular SACT topography",
"description" : "The body location used to describe the point of origin for testicular cancer or an 'Other' value, in the context of systemic anti-cancer therapy (SACT).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-testis-topography"
},
"name" : "NZ cancer urinary and/or male genital testis topography",
"description" : "The body location used to describe the point of origin for testis cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-topography"
},
"name" : "NZ cancer urinary and/or male genital topography",
"description" : "The body location used to describe the point of origin for urinary and male genital cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-urethra-topography"
},
"name" : "NZ cancer urinary and/or male genital urethra topography",
"description" : "The body location used to describe the point of origin for urethra cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-male-genital-urinary-bladder-topography"
},
"name" : "NZ cancer urinary and/or male genital urinary bladder topography",
"description" : "The body location used to describe the point of origin for urinary bladder cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-urinary-topography"
},
"name" : "NZ cancer urinary system topography",
"description" : "The body location used to describe the point of original for urinary system cancer or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-aggressive-bcell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid aggressive B cell lymphoma histology",
"description" : "Histologies used for aggressive B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-aggressive-nh-bcell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology",
"description" : "Histologies used for aggressive non-hodgkin B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-aggressive-nh-bcell-lymphoma-other-histology"
},
"name" : "NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma other histology",
"description" : "Histologies used for aggressive non-hodgkin B cell lymphoma not primary CNS or Burkitts or mediastinal lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-anus-site-histology"
},
"name" : "NZ WHO anus site histology",
"description" : "Histologies used for anal neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 7. Tumours of the anal canal, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-appendix-primary-histology"
},
"name" : "NZ WHO appendix primary histology",
"description" : "Histologies used for appendix primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix, 12. Mesenchymal tumours of the digestive system or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-appendix-site-histology"
},
"name" : "NZ WHO appendix site histology",
"description" : "Histologies used for appendix neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix,11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-biliary-tract-primary-histology"
},
"name" : "NZ WHO biliary tract primary histology",
"description" : "Histologies used for biliary tract primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 9. Tumours of the gallbladder and extrahepatic bile ducts 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Germ cell tumours only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-biliary-tract-site-histology"
},
"name" : "NZ WHO biliary tract site histology",
"description" : "Histologies used for biliary tract neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 9. Tumours of the gallbladder and extrahepatic bile ducts, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Germ cell tumours only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-bladder-primary-histology"
},
"name" : "NZ WHO urinary bladder primary histology",
"description" : "Histologies used for urinary bladder primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-bladder-site-histology"
},
"name" : "NZ WHO urinary bladder site histology",
"description" : "Histologies used for urinary bladder sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-bone-histology"
},
"name" : "NZ WHO bone histology",
"description" : "Histologies used for bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 4. Bone tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-bone-primary-histology"
},
"name" : "NZ WHO bone primary histology",
"description" : "Histologies used for bone primaries, from WHO Classification of Tumours, Soft Tissue & Bone Tumours (latest edition) - 3. Undifferentiated small round cell sarcomas of bone and soft tissue, 4. Bone tumours or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-benign-histology"
},
"name" : "NZ WHO breast benign histology",
"description" : "Histologies used for benign breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-epithelial-histology"
},
"name" : "NZ WHO breast epithelial histology",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 2. Epithelial tumours of the breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-fibroepithelial-hamartoma-histology"
},
"name" : "NZ WHO breast fibroepithelial tumour and/or hamartoma histology",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 3. Fibroepithelial tumours and hamartomas of the breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-haematolymphoid-histology"
},
"name" : "NZ WHO breast haematolymphoid histology",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 6. Haematolymphoid tumours of the breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-in-situ-carcinoma-histology"
},
"name" : "NZ WHO breast ductal carcinoma in situ histology",
"description" : "Histologies used for in situ carcinoma breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-invasive-carcinoma-histology"
},
"name" : "NZ WHO breast invasive carcinoma histology",
"description" : "Histologies used for invasive carcinoma breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-invasive-histology"
},
"name" : "NZ WHO breast invasive histology",
"description" : "Histologies used for invasive breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-male-histology"
},
"name" : "NZ WHO male breast histology",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 7. Tumours of the male breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-mesenchymal-histology"
},
"name" : "NZ WHO breast mesenchymal histology",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 5. Mesenchymal tumours of the breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-neuroendocrine-histology"
},
"name" : "NZ WHO breast neuroendocrine histology",
"description" : "Histologies used for neuroendocrine breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-nipple-histology"
},
"name" : "NZ WHO breast tumour of nipple histology",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 4. Tumours of the nipple) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-primary-histology"
},
"name" : "NZ WHO breast primary histology",
"description" : "Histologies used for breast primaries (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 2. Epithelial tumours of the breast, 3. Fibroepithelial tumours and hamartomas of the breast, 4. Tumours of the nipple, 5. Mesenchymal tumours of the breast, 7. Tumours of the male breast or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-breast-uncertain-borderline-histology"
},
"name" : "NZ WHO breast uncertain and/or borderline histology",
"description" : "Histologies used for uncertain and/or borderline breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-cns-grade"
},
"name" : "NZ WHO central nervous system tumour grade reference set",
"description" : "The grade of a cancer, assessed using the WHO Classification of Tumours central nervous system tumour grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-colorectal-primary-histology"
},
"name" : "NZ WHO colorectal primary histology",
"description" : "Histologies used for colorectal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 6. Tumours of the colon and rectum, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-colorectal-site-histology"
},
"name" : "NZ WHO colorectal site histology",
"description" : "Histologies used for colorectal neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 6. Tumours of the colon and rectum, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-differentiation-excl-undifferentiated-grade"
},
"name" : "NZ WHO malignant differentiation excluding undifferentiated grade",
"description" : "A subset of the maximal differentiation grading reference set (excluding G4; undifferentiated grade), described by World Health Organization.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-anal-canal-histology"
},
"name" : "NZ WHO digestive system anal canal histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 7. Tumours of the anal canal or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-appendix-histology"
},
"name" : "NZ WHO digestive system appendix histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 5. Tumours of the appendix or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-colon-rectum-histology"
},
"name" : "NZ WHO digestive system colon and/or rectum histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 6. Tumours of the colon and rectum or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-colon-rectum-hormone-histology"
},
"name" : "NZ WHO digestive system colon and/or rectum hormone producing tumor histology ",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours) 6. Tumours of the colon and rectum. Neuroendocrine tumour hormone producing subtype or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-germ-tumour-histology"
},
"name" : "NZ WHO digestive system germ cell tumour histology ",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 13. Other digestive system, germ cell tumour or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-haematolymphoid-histology"
},
"name" : "NZ WHO digestive system haematolymphoid histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 11. Haematolymphoid tumours of the digestive system",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-histology"
},
"name" : "NZ WHO digestive system histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-hormone-histology"
},
"name" : "NZ WHO digestive system hormone producing tumor histology ",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours) Neuroendocrine tumour hormone producing subtype or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-liver-intrahepatic-bile-duct-histology"
},
"name" : "NZ WHO digestive system liver and/or intrahepatic bile duct histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 8. Tumours of the liver and intrahepatic bile ducts or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-mucosal-melanoma-histology"
},
"name" : "NZ WHO digestive system mucosal melanoma histology ",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 13. Other digestive system, muscosal melanoma or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-pancreas-histology"
},
"name" : "NZ WHO digestive system pancreas histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 10. Tumours of the pancreas or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-primary-histology"
},
"name" : "NZ WHO digestive system primary histology",
"description" : "Histologies used for digestive system cancer types excluding heamatological histologies (WHO Classification of Tumours, Digestive System Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-digestive-small-intestine-ampulla-histology"
},
"name" : "NZ WHO digestive system small intestine and/or ampulla histology",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 4. Tumours of the small intestine and ampulla or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-fallopian-tube-primary-histology"
},
"name" : "NZ WHO fallopian tube primary histology",
"description" : "Histologies used for fallopian tube primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 5. Tumours of the fallopian tube, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-fallopian-tube-site-histology"
},
"name" : "NZ WHO fallopian tube site histology",
"description" : "Histologies used for fallopian tube sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 5. Tumours of the fallopian tube, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-breast-primary-minus-nipple-histology"
},
"name" : "NZ WHO female breast primary (no nipple) histology",
"description" : "Histologies used for female breast primaries, except for the nipple (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 2. Epithelial tumours of the breast, 3. Fibroepithelial tumours and hamartomas of the breast, 5. Mesenchymal tumours of the breast or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-fallopian-tube-histology"
},
"name" : "NZ WHO female genital fallopian tube histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 5. Tumours of the fallopian tube) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-germ-cell-histology"
},
"name" : "NZ WHO female genital germ cell histology",
"description" : "Histologies used for female genital germ cell tumours (WHO Classification of Tumours, Female Genital Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-gestational-trophoblastic-histology"
},
"name" : "NZ WHO female genital gestational trophoblastic disease histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 8. Gestational trophoblastic disease) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-haematolymphoid-histology"
},
"name" : "NZ WHO female genital haematolymphoid histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 13. Haematolymphoid proliferations and neoplasia) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-histology"
},
"name" : "NZ WHO female genital histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-melanocytic-histology"
},
"name" : "NZ WHO female genital melanocytic lesion histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 15. Melanocytic lesions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-mesenchymal-histology"
},
"name" : "NZ WHO female genital mesenchymal tumour of lower genital tract histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 14. Mesenchymal tumours of lower genital tract) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-neuroendocrine-histology"
},
"name" : "NZ WHO female genital neuroendocrine histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 12. Neuroendocrine neoplasia) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-ovary-histology"
},
"name" : "NZ WHO female genital ovary histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 2. Tumours of the ovary) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-peritoneum-histology"
},
"name" : "NZ WHO female genital peritoneum histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 4. Tumours of the peritoneum) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-primary-histology"
},
"name" : "NZ WHO female genital primary histology",
"description" : "Histologies used for female genital primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 2. Tumours of the ovary, 4. Tumours of the peritoneum, 5. Tumours of the fallopian tube, 6. Tumours of the broad ligament and other uterine ligaments, 7. Tumours of the uteine corpus, 8. Gestational trophoblastic disease, 9. Tumours of the uterine cervix, 10. Tumours of the vagina, 11. Tumours of the vulva, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-uterine-cervix-histology"
},
"name" : "NZ WHO female genital uterine cervix histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 9. Tumours of the uterine cervix) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-uterine-corpus-histology"
},
"name" : "NZ WHO female genital uterine corpus histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 7. Tumours of the uterine corpus) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-uterine-ligament-histology"
},
"name" : "NZ WHO female genital uterine ligament histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 6. Tumours of the broad ligament and other uterine ligaments) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-vagina-histology"
},
"name" : "NZ WHO female genital vagina histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 10. Tumours of the vagina) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-female-genital-vulva-histology"
},
"name" : "NZ WHO female genital vulva histology",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 11. Tumours of the vulva) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-gestational-trophoblastic-primary-histology"
},
"name" : "NZ WHO gestational trophoblastic primary histology",
"description" : "Histologies used for gestational trophoblastic primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 8. Gestational trophoblastic disease, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-acute-leukaemia-amb-lineage-histology"
},
"name" : "NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology",
"description" : "Histologies used for acute leukaemia of mixed or ambiguous lineage (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-acute-leukaemia-histology"
},
"name" : "NZ WHO haematolymphoid acute leukaemia histology",
"description" : "Histologies used for acute leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-all-bcell-histology"
},
"name" : "NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology ",
"description" : "Histologies used for B lymphoblastic leukaemia lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-all-histology"
},
"name" : "NZ WHO haematolymphoid acute lymphoblastic leukaemia histology",
"description" : "Histologies used for acute lymphoblastic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-all-tcell-histology"
},
"name" : "NZ WHO haematolymphoid T lymphoblastic leukemia histology ",
"description" : "Histologies used for t lymphoblastic leukemia (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-aml-histology"
},
"name" : "NZ WHO haematolymphoid acute myeloid leukaemia histology",
"description" : "Histologies used for acute myeloid leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-b-cell-histology"
},
"name" : "NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology",
"description" : "Histologies used for B cell lymphoid proliferations and lymphomas (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 4. B cell lymphoid proliferations and lymphomas) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-b-cell-lymphoid-histology"
},
"name" : "New Zealand WHO haematolymphoid B cell lymphoid neoplasm histology",
"description" : "Histologies used for B-cell lymphoid neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) which are not Castleman disease, Acute lymphoblastic leukaemia\r, Indolent non-Hodgkin B cell lymphoma, Aggressive non-Hodgkin B cell lymphoma, Hodgkin lymphoma or Plasma cell disorders or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-b-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid B cell lymphoma histology",
"description" : "Histologies used for B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-bl-histology"
},
"name" : "NZ WHO haematolymphoid Burkitt lymphoma histology",
"description" : "Histologies used for Burkitt lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-castleman-disorder-histology"
},
"name" : "New Zealand WHO haematolymphoid Castleman disease histology",
"description" : "Histologies used for Castleman disease (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-cel-histology"
},
"name" : "NZ WHO haematolymphoid chronic eosinophilic leukaemia histology",
"description" : "Histologies used for chronic eosinophilic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-chronic-leukaemia-histology"
},
"name" : "NZ WHO haematolymphoid chronic leukaemia histology",
"description" : "Histologies used for chronic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-cll-sll-histology"
},
"name" : "NZ WHO haematolymphoid chronic lymphocytic leukaemia/small lymphocytic lymphoma histology",
"description" : "Histologies used for chronic lymphocytic leukaemia/small lymphocytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-cml-histology"
},
"name" : "NZ WHO haematolymphoid chronic myeloid leukaemia histology",
"description" : "Histologies used for chronic myeloid leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-cnl-histology"
},
"name" : "NZ WHO haematolymphoid chronic neutrophilic leukaemia histology",
"description" : "Histologies used for chronic neutrophilic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-cut-mastocytosis-histology"
},
"name" : "NZ WHO haematolymphoid cutaneous mastocytosis histology",
"description" : "Histologies used for cutaneous mastocytosis (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-cutaneous-t-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology",
"description" : "Histologies used for primary cutaneous T cell lymphoproliferative disorder (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-dlbcl-histology"
},
"name" : "NZ WHO haematolymphoid diffuse large B cell lymphoma histology",
"description" : "Histologies used for diffuse large B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-et-histology"
},
"name" : "NZ WHO haematolymphoid essential thrombocythaemia histology",
"description" : "Histologies used for essential thrombocythemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoid-histology"
},
"name" : "NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology",
"description" : "Histologies used for extranodal NK cell and T cell lymphoid proliferation (WHO Classification of Tumours, Haematolymphoid Tumours,latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology",
"description" : "Histologies used for extranodal NK cell and T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-fl-histology"
},
"name" : "NZ WHO haematolymphoid follicular lymphoma histology",
"description" : "Histologies used for follicular lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-hcl-histology"
},
"name" : "NZ WHO haematolymphoid hairy cell leukaemia histology",
"description" : "Histologies used for hairy cell leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-histiocytic-histology"
},
"name" : "NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology",
"description" : "Histologies used for histiocytic and dendritic cell neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 3. Histiocytic/Dendritic cell neoplasms) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-histology"
},
"name" : "NZ WHO hematolymphoid tumor histology",
"description" : "Histologies used for haematolymphoid cancer types (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-hl-histology"
},
"name" : "NZ WHO haematolymphoid Hodgkin lymphoma histology",
"description" : "Histologies used for Hodgkin lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-intestinal-nk-t-cell-lymphoid-histology"
},
"name" : "NZ WHO classification of tumours haematolymphoid intestinal T-cell AND/OR natural killer cell lymphoid proliferation histology reference set",
"description" : "Histologies used for intestinal T-cell AND/OR natural killer cell lymphoid proliferation (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-leukaemia-histology"
},
"name" : "NZ WHO haematolymphoid leukaemia histology",
"description" : "Histologies used for leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid lymphoma histology",
"description" : "Histologies used for lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-lymphoplasmacytic-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology",
"description" : "Histologies used for lymphoplasmacytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mastocytosis-histology"
},
"name" : "NZ WHO haematolymphoid mastocytosis histology",
"description" : "Histologies used for mastocytosis (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mastocytosis-other-histology"
},
"name" : "NZ WHO haematolymphoid mastocytosis other histology",
"description" : "Histologies used for mastocytosis which are not systemic or cutaneous or mast cell sarcoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mc-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid mantle cell lymphoma histology",
"description" : "Histologies used for mantle cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mds-myeloproliferative-histology"
},
"name" : "NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology ",
"description" : "Histologies used for myelodysplastic and myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mds-myeloproliferative-other-histology"
},
"name" : "NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology",
"description" : "Histologies used for myelodysplastic and myeloproliferative neoplasm not chronic myelomonocytic leukemia (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mediastinal-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid mediastinal large B cell lymphoma histology",
"description" : "Histologies used for mediastinal large B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mpn-other-histology"
},
"name" : "NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology",
"description" : "Histologies used for myeloproliferative neoplasm which are not primary myelofibrosis, essential thrombocythemia, polycythemia vera, chronic myeloid leukaemia, chronic eosinophilic leukaemia, juvenile myelomonocytic leukaemia, (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myelofibrosis-histology"
},
"name" : "NZ WHO haematolymphoid primary myelofibrosis histology",
"description" : "Histologies used for primary myelofibrosis (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myeloid-histology"
},
"name" : "NZ WHO hematolymphoid myeloid proliferation or neoplasm histology",
"description" : "Histologies used for myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 2. Myeloid proliferations and neoplasms) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myeloid-lymphoid-gene-histology"
},
"name" : "NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology ",
"description" : "Histologies used for myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myeloid-other-histology"
},
"name" : "New Zealand WHO haematolymphoid myeloid proliferation or neoplasm other histology",
"description" : "Histologies used for other myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myeloid-pre-histology"
},
"name" : "NZ WHO haematolymphoid myeloid precursor lesion histology ",
"description" : "Histologies used for myeloid precursor lesion (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myeloma-histology"
},
"name" : "NZ WHO haematolymphoid myeloma histology",
"description" : "Histologies used for myeloma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-myeloproliferative-neoplasm-histology"
},
"name" : "NZ WHO haematology chronic myeloproliferative neoplasm histology ",
"description" : "Histologies used for chronic myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-mzl-histology"
},
"name" : "NZ WHO haematolymphoid marginal zone lymphoma histology",
"description" : "Histologies used for marginal zone lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-nhl-histology"
},
"name" : "NZ WHO haematolymphoid non-Hodgkin lymphoma histology",
"description" : "Histologies used for non-Hodgkin lymphoma (WHO Classification of tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-nk-t-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid NK/T cell lymphoma histology",
"description" : "Histologies used for NK cell and T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-plasma-cell-histology"
},
"name" : "NZ WHO haematolymphoid plasma cell neoplasms and/or other diseases with paraproteins histology",
"description" : "Histologies used for plasma cell neoplasms and/or other diseases with paraproteins (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-primary-cns-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid primary CNS lymphoma histology",
"description" : "Histologies used for primary central nervous system lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-pv-histology"
},
"name" : "NZ WHO haematolymphoid polycythaemia vera histology",
"description" : "Histologies used for polycythemia vera (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-sll-histology"
},
"name" : "NZ WHO haematolymphoid small lymphocytic lymphoma histology",
"description" : "Histologies used for small lymphocytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-stroma-histology"
},
"name" : "NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology",
"description" : "Histologies used for stroma-derived neoplasms of lymphoid tissues (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 6. Stroma-derived neoplasms of lymphoid tissues) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-sys-mastocytosis-histology"
},
"name" : "NZ WHO haematolymphoid systemic mastocytosis histology",
"description" : "Histologies used for systemic mastocytosis (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-systemic-mastocytosis-histology"
},
"name" : "NZ WHO haematolymphoid systemic mastocytosis histology",
"description" : "Histologies used for systemic mastocytosis (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-haematology-t-nk-cell-other-histology"
},
"name" : "NZ WHO haematolymphoid T-cell AND/OR natural killer cell neoplasm other histology",
"description" : "Histologies used for T-cell AND/OR natural killer cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-heart-primary-histology"
},
"name" : "NZ WHO heart primary histology",
"description" : "Histologies used for heart primaries (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 4. Tumours of the heart, 5. Mesenchymal tumours of the thorax, 7. Germ cell tumours of the mediastinum and 9. Ectopic tumours of thyroid and parathyroid origin) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-hep-pan-bil-primary-histology"
},
"name" : "NZ WHO hepatopancreaticobiliary primary histology",
"description" : "Histologies used for hepatopancreaticobiliary primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 8. Tumours of the liver and intrahepatic bile ducts, 9. Tumours of the gallbladder and extrahepatic bile ducts, 10. Tumours of the pancreas, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Germ cell tumours only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-histology-cll-histology"
},
"name" : "NZ WHO haematolymphoid chronic lymphocytic leukaemia histology",
"description" : "Histologies used for chronic lymphocytic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-histology-dendritic-histology"
},
"name" : "NZ WHO haematolymphoid dendritic cell neoplasm histology ",
"description" : "Histologies used for dendritic cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-histology"
},
"name" : "NZ WHO histology",
"description" : "Histologies used for any cancer type (WHO Classification of Tumours, latest editions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-indolent-b-cell-lymphoma-other-histology"
},
"name" : "NZ WHO haematolymphoid indolent B cell lymphoma other histology",
"description" : "Histologies used for other indolent B cell lymphoma not Chronic lymphocytic leukaemia and/or small lymphocytic lymphoma, Monoclonal B cell lymphocytosis, Hairy cell leukaemia, Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinaemia), Marginal zone lymphoma or Follicular lymphoma Mantle cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-indolent-bcell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid indolent B cell lymphoma histology",
"description" : "Histologies used for indolent B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-indolent-nh-b-cell-lymphoma-other-histology"
},
"name" : "NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology",
"description" : "Histologies used for other indolent non-hodgkin B cell lymphoma not Chronic lymphocytic leukaemia and/or small lymphocytic lymphoma, Monoclonal B cell lymphocytosis, Hairy cell leukaemia, Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinaemia), Marginal zone lymphoma or Follicular lymphoma\nMantle cell lymphoma(WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-kidney-primary-histology"
},
"name" : "NZ WHO kidney primary histology",
"description" : "Histologies used for kidney primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-kidney-site-histology"
},
"name" : "NZ WHO kidney site histology",
"description" : "Histologies used for kidney sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-liver-primary-histology"
},
"name" : "NZ WHO liver primary histology",
"description" : "Histologies used for liver primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 8. Tumours of the liver and intrahepatic bile ducts,12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Germ cell tumours only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-liver-site-histology"
},
"name" : "NZ WHO liver site histology",
"description" : "Histologies used for liver neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 8. Tumours of the liver and intrahepatic bile ducts, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Germ cell tumours only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-lower-gastro-primary-histology"
},
"name" : "NZ WHO lower gastrointestinal primary histology",
"description" : "Histologies used for lower gastrointestinal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix, 6. Tumours of the colon and rectum, 7. Tumours of the anal canal, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-lower-gastro-site-histology"
},
"name" : "NZ WHO lower gastrointestinal site histology",
"description" : "Histologies used for lower gastrointestinal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix, 6. Tumours of the colon and rectum, 7. Tumours of the anal canal, 11. Haematolymphoid tumours of the digestive system 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-lung-primary-histology"
},
"name" : "NZ WHO lung primary histology",
"description" : "Histologies used for lung primaries (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 2. Tumours of the lung and 5. Mesenchymal tumours of the thorax) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-lung-site-histology"
},
"name" : "NZ WHO lung site histology",
"description" : "Histologies used for lung neoplasms (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 2. Tumours of the lung and 5. Mesenchymal tumours of the thorax) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-male-breast-primary-histology"
},
"name" : "NZ WHO male breast primary histology",
"description" : "Histologies used for male breast primaries (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 3. Fibroepithelial tumours and hamartomas of the breast, 4. Tumours of the nipple, 5. Mesenchymal tumours of the breast, 7. Tumours of the male breast or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-male-breast-primary-minus-nipple-histology"
},
"name" : "NZ WHO male breast primary (no nipple) histology",
"description" : "Histologies used for male breast primaries, except for the nipple (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 3. Fibroepithelial tumours and hamartomas of the breast, 5. Mesenchymal tumours of the breast, 7. Tumours of the male breast or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-male-genital-primary-histology"
},
"name" : "NZ WHO male genital primary histology",
"description" : "Histologies used for male genital primary, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 6. Tumours of the testis, 7. Tumours of the testicular adnexa, 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-male-genital-site-histology"
},
"name" : "NZ WHO male genital site histology",
"description" : "Histologies used for male genital sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 6. Tumours of the testis, 7. Tumours of the testicular adnexa, 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-mature-tnk-cell-histology"
},
"name" : "NZ WHO haematolymphoid mature T cell and/or natural killer cell neoplasm histology ",
"description" : "Histologies used for mature T cell and/or natural killer cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-mature-tnk-cell-other-histology"
},
"name" : "NZ WHO haematolymphoid mature T-cell AND/OR natural killer cell neoplasm other histology",
"description" : "Histologies used for mature T-cell AND/OR natural killer cell neoplasm not peripheral T cell or extranodal NK/T cell or primary T cell cutaneous lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-mo-histology"
},
"name" : "NZ WHO medical oncology histology",
"description" : "Histologies used for any medical oncology cancer site (WHO Classification of Tumours, latest editions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-mo-primary-histology"
},
"name" : "NZ WHO medical oncology primary histology",
"description" : "Histologies used for any medical oncology primary type (WHO Classification of Tumours, latest editions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-neuroendocrine-grade"
},
"name" : "NZ WHO neuroendocrine tumour grade",
"description" : "The grade of a cancer, assessed using the WHO Classification of Tumours neuroendocrine tumour grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-oesophagus-primary-histology"
},
"name" : "NZ WHO oesophagus primary histology",
"description" : "Histologies used for oesophagus primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-oesophagus-site-histology"
},
"name" : "NZ WHO oesophagus site histology",
"description" : "Histologies used for oesophagus neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-ovarian-germ-cell-primary"
},
"name" : "NZ WHO ovarian germ cell primary histology",
"description" : "Histologies used for ovarian germ cell primaries (from WHO Classification of Tumours, Female Genital Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-ovary-site-histology"
},
"name" : "NZ WHO ovary site histology",
"description" : "Histologies used for ovary sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 2. Tumours of the ovary, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-pancreas-primary-histology"
},
"name" : "NZ WHO pancreas primary histology",
"description" : "Histologies used for pancreatic primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 10. Tumours of the pancreas,12. Mesenchymal tumours of the digestive system) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-pancreas-site-histology"
},
"name" : "NZ WHO pancreas site histology",
"description" : "Histologies used for pancreatic neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 10. Tumours of the pancreas, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-penis-primary-histology"
},
"name" : "NZ WHO penis primary histology",
"description" : "Histologies used for penis primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-penis-site-histology"
},
"name" : "NZ WHO penis site histology",
"description" : "Histologies used for penis sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-pericardium-site-histology"
},
"name" : "NZ WHO pericardium site histology",
"description" : "Histologies used for pericardium neoplasms (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 3. Tumours of the pleura and pericardium, 5. Mesenchymal tumours of the thorax, 7. Germ cell tumours of the mediastinum, 8. Haematolymphoid tumours of the mediastinum, and 9. Ectopic tumours of thyroid and parathyroid origin) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-peritoneum-primary-histology"
},
"name" : "NZ WHO peritoneum primary histology",
"description" : "Histologies used for peritoneum primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 4. Tumours of the peritoneum, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-peritoneum-site-histology"
},
"name" : "NZ WHO peritoneum site histology",
"description" : "Histologies used for peritoneum sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 4. Tumours of the peritoneum, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-pleura-primary-histology"
},
"name" : "NZ WHO pleural primary histology",
"description" : "Histologies used for pleural primaries (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 3. Tumours of the pleura and pericardium (excluding haematolymphoid tumours) and 5. Mesenchymal tumours of the thorax) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-pleura-site-histology"
},
"name" : "NZ WHO pleural site histology",
"description" : "Histologies used for pleural neoplasms (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 3. Tumours of the pleura and pericardium and 5. Mesenchymal tumours of the thorax) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-prostate-primary-histology"
},
"name" : "NZ WHO prostate primary histology",
"description" : "Histologies used for prostate primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-prostate-site-histology"
},
"name" : "NZ WHO prostate site histology",
"description" : "Histologies used for prostate sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-renal-pelvis-ureter-site-histology"
},
"name" : "NZ WHO renal pelvis and/or ureter site histology",
"description" : "Histologies used for renal pelvis and/or ureter sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-small-intestine-primary-histology"
},
"name" : "NZ WHO small intestine primary histology",
"description" : "Histologies used for small intestine primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 4. Tumours of the small intestine and ampulla,, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-small-intestine-site-histology"
},
"name" : "NZ WHO small intestine site histology",
"description" : "Histologies used for small intestine neoplasms(from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 4. Tumours of the small intestine and ampulla, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-soft-tissue-bone-histology"
},
"name" : "NZ WHO soft tissue and/or bone histology",
"description" : "Histologies used for soft tissue and/or bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-soft-tissue-bone-primary-histology"
},
"name" : "NZ WHO soft tissue and/or bone primary histology",
"description" : "Histologies used for soft tissue and/or bone primaries, from WHO Classification of Tumours, Soft Tissue & Bone Tumours (latest edition) - 2. Soft tissue tumours, 3. Undifferentiated small round cell sarcomas of bone and soft tissue, 4. Bone tumours or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-soft-tissue-bone-undiff-sarcoma-histology"
},
"name" : "NZ WHO soft tissue and/or bone undifferentiated small round cell sarcoma histology",
"description" : "Histologies used for soft tissue and/or bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 3. Undifferentiated small round cell sarcoma of bone and soft tissue) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-soft-tissue-histology"
},
"name" : "NZ WHO soft tissue histology",
"description" : "Histologies used for soft tissue cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 2. Soft tissue tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-soft-tissue-site-histology"
},
"name" : "NZ WHO soft tissue site histology",
"description" : "Histologies used for soft tissue sites, from WHO Classification of Tumours, Soft Tissue & Bone Tumours (latest edition) - 2. Soft tissue tumours, 3. Undifferentiated small round cell sarcomas of bone and soft tissue or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-stomach-primary-histology"
},
"name" : "NZ WHO stomach primary histology",
"description" : "Histologies used for stomach primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 3. Tumours of the stomach,12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-stomach-site-histology"
},
"name" : "NZ WHO stomach site histology",
"description" : "Histologies used for stomach neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 3. Tumours of the stomach, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-testicular-adnexa-primary-histology"
},
"name" : "NZ WHO testicular adnexa primary histology",
"description" : "Histologies used for testicular adnexa primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 7. Tumours of the testicular adnexa, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-testicular-adnexa-site-histology"
},
"name" : "NZ WHO testicular adnexa site histology",
"description" : "Histologies used for testicular adnexa sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 7. Tumours of the testicular adnexa, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-testicular-other-primary-histology"
},
"name" : "NZ WHO testicular other primary histology",
"description" : "Histologies used for testicular other primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-testicular-seminoma-primary-histology"
},
"name" : "NZ WHO testicular seminoma primary histology",
"description" : "Histologies used for testicular seminoma primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-testis-primary-histology"
},
"name" : "NZ WHO testis primary histology",
"description" : "Histologies used for testies primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 6. Tumours of the testis, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-testis-site-histology"
},
"name" : "NZ WHO testis site histology",
"description" : "Histologies used for testies sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 6. Tumours of the testis, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-haematolymphoid-mediastinum-histology"
},
"name" : "NZ WHO thoracic mediastinum haematolymphoid histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 8. Haematolymphoid tumours of the mediastinum",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-heart-histology"
},
"name" : "NZ WHO thoracic heart histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 4. Tumours of the heart or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-histology"
},
"name" : "NZ WHO thoracic histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-lung-histology"
},
"name" : "NZ WHO thoracic lung histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 2. Tumours of the lung or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-mesenchymal-histology"
},
"name" : "NZ WHO thoracic mesenchymal thorax histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 5. Mesenchymal tumours of the thorax or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-non-small-cell-lung-histology"
},
"name" : "NZ WHO thoracic non small cell lung histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 2. Tumours of the lung. Non small cell histology or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-pleura-pericardium-histology"
},
"name" : "NZ WHO thoracic pleura and/or pericardium histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 3. Tumours of the pleura and pericardium or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-small-cell-lung-histology"
},
"name" : "NZ WHO thoracic small cell lung histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 2. Tumours of the lung. Small cell histology or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thoracic-thymus-histology"
},
"name" : "NZ WHO thoracic thymus histology",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 6. Tumours of the thymus or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-thymus-primary-histology"
},
"name" : "NZ WHO thymus primary histology",
"description" : "Histologies used for thymus primaries (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 5. Mesenchymal tumours of the thorax, 6. Tumours of the thymus, 7. Germ cell tumours of the mediastinum and 9. Ectopic tumours of thyroid and parathyroid origin) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-upper-gastro-primary-histology"
},
"name" : "NZ WHO upper gastrointestinal primary histology",
"description" : "Histologies used for upper gastrointestinal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 3. Tumours of the stomach, 4. Tumours of the small intestine and ampulla, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-upper-gastro-site-histology"
},
"name" : "NZ WHO upper gastrointestinal site histology",
"description" : "Histologies used for upper gastrointestinal neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 3. Tumours of the stomach, 4. Tumours of the small intestine and ampulla, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urethra-primary-histology"
},
"name" : "NZ WHO urethra primary histology",
"description" : "Histologies used for urethra primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urethra-site-histology"
},
"name" : "NZ WHO urethra site histology",
"description" : "Histologies used for urethra sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-haematolymphoid-histology"
},
"name" : "NZ WHO urinary and/or male genital haematolymphoid histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 11. Haematolymphoid tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-kidney-histology"
},
"name" : "NZ WHO urinary and/or male genital kidney histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 2. Tumours of the kidney) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-melanocytic-histology"
},
"name" : "NZ WHO urinary and/or male genital melanocytic lesion histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 12. Melanocytic lesions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-mesenchymal-histology"
},
"name" : "NZ WHO urinary and/or male genital mesenchymal histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 10. Mesenchymal tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-neuroendocrine-histology"
},
"name" : "NZ WHO urinary and/or male genital neuroendocrine histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 9. Neuroendocrine neoplasms) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-penis-scrotum-histology"
},
"name" : "NZ WHO urinary and/or male genital penis and/or scrotum histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 8. Tumours of the penis and scrotum) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-primary-histology"
},
"name" : "NZ WHO urinary and/or male genital primary histology",
"description" : "Histologies used for urinary and male genital primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 3. Tumours of the urinary tract, 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 6. Tumours of the testis, 7. Tumours of the testicular adnexa, 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-prostate-histology"
},
"name" : "NZ WHO urinary and/or male genital prostate histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 4. Tumours of the prostate) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-seminal-vesicle-histology"
},
"name" : "NZ WHO urinary and/or male genital seminal vesicle histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 5. Tumours of the seminal vesicle) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-testicular-adnexa-histology"
},
"name" : "NZ WHO urinary and/or male genital testicular adnexa histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 7. Tumours of the tesicular adnexa) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-testis-germ-cell-histology"
},
"name" : "NZ WHO urinary and/or male genital testis germ cell histology",
"description" : "Histologies used for germ cell tumours of testis (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-testis-histology"
},
"name" : "NZ WHO urinary and/or male genital testis histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 6. Tumours of the testis) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-male-genital-urinary-tract-histology"
},
"name" : "NZ WHO urinary and/or male genital urinary tract histology",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 3. Tumours of the urinary tract) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-system-primary-histology"
},
"name" : "NZ WHO urinary system primary histology",
"description" : "Histologies used for urinary system primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-urinary-system-site-histology"
},
"name" : "NZ WHO urinary system site histology",
"description" : "Histologies used for urinary system sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-uterine-cervix-primary-histology"
},
"name" : "NZ WHO uterine cervix primary histology",
"description" : "Histologies used for uterine cervix primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 9. Tumours of the uterine cervix, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-uterine-cervix-site-histology"
},
"name" : "NZ WHO uterine cervix site histology",
"description" : "Histologies used for uterine cervix sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 9. Tumours of the uterine cervix, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-uterine-corpus-primary-histology"
},
"name" : "NZ WHO uterine corpus primary histology",
"description" : "Histologies used for uterine corpus primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 7. Tumours of the uterine corpus, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-uterine-corpus-site-histology"
},
"name" : "NZ WHO uterine corpus site histology",
"description" : "Histologies used for uterine corpus sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 7. Tumours of the uterine corpus, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-uterine-ligament-primary-histology"
},
"name" : "NZ WHO uterine ligament primary histology",
"description" : "Histologies used for uterine ligament primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 6. Tumours of the broad ligament and other uterine ligaments, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-uterine-ligament-site-histology"
},
"name" : "NZ WHO uterine ligament site histology",
"description" : "Histologies used for uterine ligament sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 6. Tumours of the broad ligament and other uterine ligaments, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-vagina-primary-histology"
},
"name" : "NZ WHO vagina primary histology",
"description" : "Histologies used for vagina primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 10. Tumours of the vagina, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-vagina-site-histology"
},
"name" : "NZ WHO vagina site histology",
"description" : "Histologies used for vagina sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 10. Tumours of the vagina, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-vulva-primary-histology"
},
"name" : "NZ WHO vulva primary histology",
"description" : "Histologies used for vulva primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 11. Tumours of the vulva, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who-vulva-site-histology"
},
"name" : "NZ WHO vulva site histology",
"description" : "Histologies used for vulva sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 11. Tumours of the vulva, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-aggressive-nh-bcell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition)",
"description" : "Histologies used for aggressive non-Hodgkin B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-bone-histology"
},
"name" : "NZ WHO bone histology (5th edition)",
"description" : "Histologies used for bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, 5th edition - 4. Bone tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-behaviour-free-histology"
},
"name" : "NZ WHO breast behaviour free histology (5th edition)",
"description" : "Histologies used for behaviour free breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-benign-histology"
},
"name" : "NZ WHO breast benign histology (5th edition)",
"description" : "Histologies used for benign breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-fibroepithelial-hamartoma-histology"
},
"name" : "NZ WHO breast fibroepithelial tumour and/or hamartoma histology (5th edition)",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition - 3. Fibroepithelial tumours and hamartomas of the breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-histology"
},
"name" : "NZ WHO breast histology (5th edition)",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-in-situ-carcinoma-histology"
},
"name" : "NZ WHO breast ductal carcinoma in situ histology (5th edition)",
"description" : "Histologies used for in situ carcinoma breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-invasive-carcinoma-histology"
},
"name" : "NZ WHO breast invasive carcinoma histology (5th edition)",
"description" : "Histologies used for invasive carcinoma breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-invasive-histology"
},
"name" : "NZ WHO breast invasive histology (5th edition)",
"description" : "Histologies used for invasive breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-male-histology"
},
"name" : "NZ WHO male breast histology (5th edition)",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition - 7. Tumours of the male breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-mesenchymal-histology"
},
"name" : "NZ WHO breast mesenchymal histology (5th edition)",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition - 5. Mesenchymal tumours of the breast) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-nipple-histology"
},
"name" : "NZ WHO breast tumour of nipple histology (5th edition)",
"description" : "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition - 4. Tumours of the nipple) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-breast-uncertain-borderline-histology"
},
"name" : "NZ WHO breast uncertain and/or borderline histology (5th edition)",
"description" : "Histologies used for uncertain and/or borderline breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-cns-grade"
},
"name" : "NZ WHO (5th edition) central nervous system tumour grade",
"description" : "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) central nervous system tumour grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-differentiation-excl-undifferentiated-grade"
},
"name" : "NZ WHO (5th edition) malignant differentiation excluding undifferentiated grade",
"description" : "A subset of the maximal differentiation grading reference set (excluding G4; undifferentiated grade), described by World Health Organization (5th edition).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-differentiation-grade"
},
"name" : "NZ WHO (5th edition) malignant differentiation grade",
"description" : "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) malignant differentiation grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-anal-canal-histology"
},
"name" : "NZ WHO digestive system anal canal histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 7. Tumours of the anal canal or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-appendix-histology"
},
"name" : "NZ WHO digestive system appendix histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 5. Tumours of the appendix or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-colon-rectum-hormone-histology"
},
"name" : "NZ WHO digestive system colon and/or rectum hormone producing tumor histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 6. Tumours of the colon and rectum. Neuroendocrine tumour hormone producing subtype or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-germ-tumour-histology"
},
"name" : "NZ WHO digestive system germ cell tumour histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 13. Other digestive system, germ cell tumour or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-haematolymphoid-histology"
},
"name" : "NZ WHO digestive system haematolymphoid histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 11. Haematolymphoid tumours of the digestive system or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-hormone-histology"
},
"name" : "NZ WHO digestive system hormone producing tumor histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) Neuroendocrine tumour hormone producing subtype or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-liver-intrahepatic-bile-duct-histology"
},
"name" : "NZ WHO digestive system liver and/or intrahepatic bile duct histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 8. Tumours of the liver and intrahepatic bile ducts or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-mucosal-melanoma-histology"
},
"name" : "NZ WHO digestive system mucosal melanoma histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 13. Other digestive system, muscosal melanoma or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-oesophagus-histology"
},
"name" : "NZ WHO digestive system oesophagus histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 2. Tumours of the oesophagus or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-pancreas-histology"
},
"name" : "NZ WHO digestive system pancreas histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 10. Tumours of the pancreas or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-small-intestine-ampulla-histology"
},
"name" : "NZ WHO digestive system small intestine and/or ampulla histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 4. Tumours of the small intestine and ampulla or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-digestive-stomach-histology"
},
"name" : "NZ WHO digestive system stomach histology (5th edition)",
"description" : "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 3. Tumours of the stomach or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-fallopian-tube-histology"
},
"name" : "NZ WHO female genital fallopian tube histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 5. Tumours of the fallopian tube) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-germ-cell-histology"
},
"name" : "NZ WHO female genital germ cell histology (5th edition)",
"description" : "Histologies used for female genital germ cell tumours (WHO Classification of Tumours, Female Genital Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-haematolymphoid-histology"
},
"name" : "NZ WHO female genital haematolymphoid histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 13. Haematolymphoid proliferations and neoplasia) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-histology"
},
"name" : "NZ WHO female genital histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-melanocytic-histology"
},
"name" : "NZ WHO female genital melanocytic lesion histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 15. Melanocytic lesions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-mesenchymal-histology"
},
"name" : "NZ WHO female genital mesenchymal tumour of lower genital tract histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 14. Mesenchymal tumours of lower genital tract) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-neuroendocrine-histology"
},
"name" : "NZ WHO female genital neuroendocrine histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 12. Neuroendocrine neoplasia) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-ovary-histology"
},
"name" : "NZ WHO female genital ovary histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 2. Tumours of the ovary) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-uterine-cervix-histology"
},
"name" : "NZ WHO female genital uterine cervix histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 9. Tumours of the uterine cervix) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-uterine-corpus-histology"
},
"name" : "NZ WHO female genital uterine corpus histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 7. Tumours of the uterine corpus) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-vagina-histology"
},
"name" : "NZ WHO female genital vagina histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 10. Tumours of the vagina) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-female-genital-vulva-histology"
},
"name" : "NZ WHO female genital vulva histology (5th edition)",
"description" : "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 11. Tumours of the vulva) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-acute-leukaemia-amb-lineage-histology"
},
"name" : "NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition)",
"description" : "Histologies used for acute leukaemia of mixed or ambiguous lineage (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-acute-leukaemia-histology"
},
"name" : "NZ WHO haematolymphoid acute leukaemia histology (5th edition)",
"description" : "Histologies used for acute leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-all-bcell-histology"
},
"name" : "NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology (5th edition)",
"description" : "Histologies used for B lymphoblastic leukaemia lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-all-histology"
},
"name" : "NZ WHO haematolymphoid acute lymphoblastic leukaemia histology (5th edition)",
"description" : "Histologies used for acute lymphoblastic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-all-tcell-histology"
},
"name" : "NZ WHO haematolymphoid T lymphoblastic leukemia histology (5th edition)",
"description" : "Histologies used for T lymphoblastic leukemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-aml-histology"
},
"name" : "NZ WHO haematolymphoid acute myeloid leukaemia histology (5th edition)",
"description" : "Histologies used for acute myeloid leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-amyloidosis-histology"
},
"name" : "NZ WHO haematolymphoid amyloidosis histology (5th edition)",
"description" : "Histologies used for amyloidosis (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-b-cell-histology"
},
"name" : "NZ WHO haematolymphoid B cell lymphoid proliferation or lymphoma histology (5th edition)",
"description" : "Histologies used for B cell lymphoid proliferations and lymphomas (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition - 4. B cell lymphoid proliferations and lymphomas) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-b-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid B cell lymphoma histology (5th edition)",
"description" : "Histologies used for B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-bl-histology"
},
"name" : "NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition)",
"description" : "Histologies used for Burkitt lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-chronic-leukaemia-histology"
},
"name" : "NZ WHO haematolymphoid chronic leukaemia histology (5th edition)",
"description" : "Histologies used for chronic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-cml-histology"
},
"name" : "NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition)",
"description" : "Histologies used for chronic myeloid leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-dlbcl-histology"
},
"name" : "NZ WHO haematolymphoid diffuse large B cell lymphoma histology (5th edition)",
"description" : "Histologies used for diffuse large B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-et-histology"
},
"name" : "NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition)",
"description" : "Histologies used for essential thrombocythemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-extranod-nk-t-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition)",
"description" : "Histologies used for extranodal NK cell and T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-fl-histology"
},
"name" : "NZ WHO haematolymphoid follicular lymphoma histology (5th edition)",
"description" : "Histologies used for follicular lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-histiocytic-histology"
},
"name" : "NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition)",
"description" : "Histologies used for histiocytic and dendritic cell neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition - 3. Histiocytic/Dendritic cell neoplasms) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-histology"
},
"name" : "NZ WHO haematolymphoid tumour histology (5th edition)",
"description" : "Histologies used for haematolymphoid cancer types (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-hl-histology"
},
"name" : "NZ WHO haematolymphoid Hodgkin lymphoma histology (5th edition)",
"description" : "Histologies used for Hodgkin lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-leukaemia-histology"
},
"name" : "NZ WHO haematolymphoid leukaemia histology (5th edition)",
"description" : "Histologies used for leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid lymphoma histology (5th edition)",
"description" : "Histologies used for lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-lymphoplasmacytic-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition)",
"description" : "Histologies used for lymphoplasmacytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-mastocytosis-histology"
},
"name" : "NZ WHO haematolymphoid mastocytosis histology (5th edition)",
"description" : "Histologies used for mastocytosis (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-mc-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition)",
"description" : "Histologies used for mantle cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-mds-histology"
},
"name" : "NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition)",
"description" : "Histologies used for myelodysplastic syndrome (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-mds-myeloproliferative-histology"
},
"name" : "NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition)",
"description" : "Histologies used for myelodysplastic and myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-myelofibrosis-histology"
},
"name" : "NZ WHO haematolymphoid primary myelofibrosis histology (5th edition)",
"description" : "Histologies used for primary myelofibrosis (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-myeloid-histology"
},
"name" : "NZ WHO haematolymphoid myeloid proliferation or neoplasm histology (5th edition)",
"description" : "Histologies used for myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition - 2. Myeloid proliferations and neoplasms) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-myeloid-lymphoid-gene-histology"
},
"name" : "NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition)",
"description" : "Histologies used for myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-myeloid-pre-histology"
},
"name" : "NZ WHO haematolymphoid myeloid precursor lesion histology (5th edition)",
"description" : "Histologies used for myeloid precursor lesion (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-myeloproliferative-neoplasm-histology"
},
"name" : "NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition)",
"description" : "Histologies used for chronic myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th editions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-mzl-histology"
},
"name" : "NZ WHO haematolymphoid marginal zone lymphoma histology (5th edition)",
"description" : "Histologies used for marginal zone lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-nhl-histology"
},
"name" : "NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition)",
"description" : "Histologies used for non Hodgkin lymphoma (WHO Classification of tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-nk-t-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid NK/T cell lymphoma histology (5th edition)",
"description" : "Histologies used for NK cell and T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-peripheral-t-cell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition)",
"description" : "Histologies used for peripheral T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-plasma-cell-histology"
},
"name" : "NZ WHO haematolymphoid plasma cell neoplasms and/or other diseases with paraproteins histology (5th edition)",
"description" : "Histologies used for plasma cell neoplasms and/or other diseases with paraproteins (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-primary-cns-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid primary CNS lymphoma histology (5th edition)",
"description" : "Histologies used for primary central nervous system lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-pv-histology"
},
"name" : "NZ WHO haematolymphoid polycythaemia vera histology (5th edition)",
"description" : "Histologies used for polycythemia vera (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-sll-histology"
},
"name" : "NZ WHO haematolymphoid small lymphocytic lymphoma histology (5th edition)",
"description" : "Histologies used for small lymphocytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-stroma-histology"
},
"name" : "NZ WHO haematolymphoid stroma derived neoplasm of lymphoid tissue histology (5th edition)",
"description" : "Histologies used for stroma-derived neoplasms of lymphoid tissues (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition - 6. Stroma-derived neoplasms of lymphoid tissues) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-haematology-t-nk-cell-histology"
},
"name" : "NZ WHO haematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology (5th edition)",
"description" : "Histologies used for T cell and NK cell lymphoid proliferations and lymphomas (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition - 5. T cell and NK cell lymphoid proliferations and lymphomas) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-histology-cll-histology"
},
"name" : "NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition)",
"description" : "Histologies used for chronic lymphocytic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-histology-dendritic-histology"
},
"name" : "NZ WHO haematolymphoid dendritic cell neoplasm histology (5th edition)",
"description" : "Histologies used for dendritic cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-indolent-nh-bcell-lymphoma-histology"
},
"name" : "NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition)",
"description" : "Histologies used for indolent non-Hodgkin B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-low-high-grade"
},
"name" : "NZ WHO (5th edition) malignant low high grade",
"description" : "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) malignant low / high grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-mature-tnk-cell-histology"
},
"name" : "NZ WHO haematolymphoid mature T cell and/or natural killer cell neoplasm histology (5th edition)",
"description" : "Histologies used for mature T cell and/or natural killer cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-neuroendocrine-grade"
},
"name" : "NZ WHO (5th edition) neuroendocrine tumour grade",
"description" : "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) neuroendocrine tumour grading system.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-soft-tissue-bone-undiff-sarcoma-histology"
},
"name" : "NZ WHO soft tissue and/or bone undifferentiated small round cell sarcoma histology (5th edition)",
"description" : "Histologies used for soft tissue and/or bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, 5th edition - 3. Undifferentiated small round cell sarcoma of bone and soft tissue) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-ectopic-thyroid-parathyroid-histology"
},
"name" : "NZ WHO thoracic ectopic tumour of thyroid and/or parathyroid origin histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 9. Ectopic tumours of thyroid and parathyroid origin or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-germ-cell-mediastinum-histology"
},
"name" : "NZ WHO thoracic mediastinum germ cell histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 7. Germ cell tumours of the mediastinum or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-haematolymphoid-mediastinum-histology"
},
"name" : "NZ WHO thoracic mediastinum haematolymphoid histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 8. Haematolymphoid tumours of the mediastinum or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-heart-histology"
},
"name" : "NZ WHO thoracic heart histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 4. Tumours of the heart or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-histology"
},
"name" : "NZ WHO thoracic histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-lung-histology"
},
"name" : "NZ WHO thoracic lung histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 2. Tumours of the lung or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-non-small-cell-lung-histology"
},
"name" : "NZ WHO thoracic non small cell lung histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 2. Tumours of the lung. Non small cell histology or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-thoracic-small-cell-lung-histology"
},
"name" : "NZ WHO thoracic small cell lung histology (5th edition)",
"description" : "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 2. Tumours of the lung. Small cell histology or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-haematolymphoid-histology"
},
"name" : "NZ WHO urinary and/or male genital haematolymphoid histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 11. Haematolymphoid tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-histology"
},
"name" : "NZ WHO urinary and/or male genital histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-kidney-histology"
},
"name" : "NZ WHO urinary and/or male genital kidney histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 2. Tumours of the kidney) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-melanocytic-histology"
},
"name" : "NZ WHO urinary and/or male genital melanocytic lesion histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 12. Melanocytic lesions) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-mesenchymal-histology"
},
"name" : "NZ WHO urinary and/or male genital mesenchymal histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 10. Mesenchymal tumours) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-neuroendocrine-histology"
},
"name" : "NZ WHO urinary and/or male genital neuroendocrine histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 9. Neuroendocrine neoplasms) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-penis-scrotum-histology"
},
"name" : "NZ WHO urinary and/or male genital penis and/or scrotum histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 8. Tumours of the penis and scrotum) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-prostate-histology"
},
"name" : "NZ WHO urinary and/or male genital prostate histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 4. Tumours of the prostate) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-seminal-vesicle-histology"
},
"name" : "NZ WHO urinary and/or male genital seminal vesicle histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 5. Tumours of the seminal vesicle) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-testicular-adnexa-histology"
},
"name" : "NZ WHO urinary and/or male genital testicular adnexa histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 7. Tumours of the tesicular adnexa) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-testis-histology"
},
"name" : "NZ WHO urinary and/or male genital testis histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 6. Tumours of the testis) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/canshare-who5-urinary-male-genital-urinary-tract-histology"
},
"name" : "NZ WHO urinary and/or male genital urinary tract histology (5th edition)",
"description" : "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 3. Tumours of the urinary tract) or an 'Other' value.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/citizenship-status"
},
"name" : "NZ Citizenship status",
"description" : "Citizenship status",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/condition-clinical"
},
"name" : "Condition Clinical Status Codes",
"description" : "Preferred value set for Condition Clinical Status.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/condition-severity-uv-ips"
},
"name" : "Problem Severity - IPS",
"description" : "Problem Severity. The [condition-severity](https://www.hl7.org/fhir/R4/valueset-condition-severity.html) value set from the base Condition resource is now the preferred binding for IPS. This value set of LOINC answer codes is retained as an additional binding for backward compatibility with the prior IPS release.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/condition-severity"
},
"name" : "Condition/Diagnosis Severity",
"description" : "Preferred value set for Condition/Diagnosis severity grading.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/condition-ver-status"
},
"name" : "ConditionVerificationStatus",
"description" : "The verification status to support or decline the clinical status of the condition or diagnosis.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/contact-point-purpose"
},
"name" : "ContactPoint purpose",
"description" : "The purpose of a ContactPoint - what it is used for.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/coverage-category"
},
"name" : "Coverage category",
"description" : "New Zealand codes for Coverage category types",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/coverage-type"
},
"name" : "Coverage type",
"description" : "New Zealand codes for Coverage Types",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/covidantiviraleligibilitycriteria"
},
"name" : "COVID19 Antiviral eligibility criteria",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/current-smoking-status-uv-ips"
},
"name" : "Current Smoking Status - IPS",
"description" : "HL7 LOINC value set for smoking status. Based on the HL7 Vocab and Structured Doc WG (formerly TC) consensus - per US CDC submission 7/12/2012 for smoking status terms.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/d1adf025-b6d2-44dc-a8b1-da3adfcafa73"
},
"name" : "NZ Purpose Of Use",
"description" : "Additional codes to be incorporated with HL7 v3 Value Set Purpose of Use",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/d65235c7-94bd-4242-84ec-f7dd4fed3856"
},
"name" : "Number of cord vessels",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/datum-code"
},
"name" : "Datum codes",
"description" : "Possible datum codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/datumCode"
},
"name" : "Datum code",
"description" : "Datum codes used",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/dc8099d2-b2ae-4ab4-8d0f-9d42f696fdc7"
},
"name" : "AIR indication code",
"description" : "Coded values to describe the reason an immunisation was given. Initially drawn from legacy NIR codes and CIR SNOMED codes.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/dhb-code"
},
"name" : "NZ DHB",
"description" : "NZ District Health Board (HPI-ORG) Codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/dhb"
},
"name" : "District Health Board Identifer",
"description" : "District Health Board Identifer. Assigned by the HPI.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/document-mode"
},
"name" : "DocumentMode",
"description" : "Whether the application produces or consumes documents.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/dod-information-source"
},
"name" : "Death date Information Source",
"description" : "The source from where the date of death was sourced",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/domicile-code"
},
"name" : "Domicile Code",
"description" : "Domicile Code",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ebfb3905-c414-458e-ac40-aee9376b191c"
},
"name" : "AIR body site",
"description" : "Body sites value set for AIR immunisations",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/ec568eb5-083c-4893-a393-eecbde4028bb"
},
"name" : "Skin to skin end reason",
"description" : "Reason why initial skin to skin contact was ended",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/edd-method-uv-ips"
},
"name" : "Pregnancy Expected Delivery Date Method - IPS",
"description" : "IPS Expected Delivery Date Method",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/edqm-standardterms"
},
"name" : "EDQM - Standard Terms",
"description" : "EDQM - Standard Terms used in Switzerland (aggregations of codes of ValueSets RouteOfAdministration, Dose Form, see original codes system defined in https://standardterms.edqm.eu/#)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ethnicgroupcodelevel1"
},
"name" : "NZ ethnic group code level 1",
"description" : "NZ Ethnicity level 1 codes only.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ethnicgroupcodelevel2"
},
"name" : "NZ ethnic group code level 2",
"description" : "Ethnicity level 2 codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ethnicgrouplevel3"
},
"name" : "NZ ethnic group code level 3",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ethnicity"
},
"name" : "Ethnicity of a person",
"description" : "Codes to record a person's ethnicity, drawn from [Level 4 of the Ethnicity code system](http://aria.stats.govt.nz/aria/#ClassificationView:uri=http://stats.govt.nz/cms/ClassificationVersion/YVqOcFHSlguKkT17)\nNote that the correct version of the ethicity code system is 2.1.0",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/ethnicityL4"
},
"name" : "Level 4 ethnicity codes",
"description" : "Codes to record a person’s ethnicity, drawn from Level 4 of the Ethnicity code system \ndescribed [here](http://aria.stats.govt.nz/aria/#ClassificationView:uri=http://stats.govt.nz/cms/ClassificationVersion/YVqOcFHSlguKkT17)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/f42a2f22-aa0a-4f67-b0d6-74e78376527d"
},
"name" : "NZVX immunisation codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/feb410e5-024e-4a8b-83c9-3b6a214b0d56"
},
"name" : "Admission source code",
"description" : "Admission source code for use when reporting into National Collections",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/funded-programme"
},
"name" : "Funded Programme",
"description" : "Some sort of funded programme",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/generaldentistrydiagnostic"
},
"name" : "General dentistry diagnostic codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/healthcare-professional-roles-uv-ips"
},
"name" : "Healthcare Professional Roles - IPS",
"description" : "IPS Healthcare Professional Roles",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/healthnz-language-value-set"
},
"name" : "Health NZ language Value Set",
"description" : "ISO 639-2 language codes plus NZ sign language from ISO 639-3",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/hpi-practitionerRole-status-reason"
},
"name" : "PractitionerRole status reason",
"description" : "The reason for the current status of PractitionerRole",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/hpi-practitionerrole-status-reason"
},
"name" : "PractitionerRole status reason",
"description" : "The reason for the current status of PractitionerRole",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/information-source"
},
"name" : "Information Source",
"description" : "The source from where the value of this item was sourced",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/iso-639-2-and-3"
},
"name" : "ISO 639 2 and 3 language codes",
"description" : "iso 639-2 and 639-3 language codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/iso3166-1-2"
},
"name" : "ISO 3166-1 alpha-2 country codes",
"description" : "ISO 3166-1 alpha-2 country codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/iso639-2"
},
"name" : "ISO 639-2 Language Codes Alpha 3",
"description" : "**Description:** Codes for the representation of names of languages — Part 2: Alpha-3 code, is the second part of the ISO 639 standard, which lists codes for the representation of the names of languages. The three-letter codes given for each language in this part of the standard are referred to as Alpha-3 codes. There are 487 entries in the list of ISO 639-2 codes. There are 21 languages that have alternative codes for bibliographic or terminology purposes, this code system only contains those with terminology purposes. Administered by SIL",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/iso639-3"
},
"name" : "ISO 639-3 Language Codes Alpha 3",
"description" : "**Description:** ISO 639-3 is a code that aims to define three-letter identifiers for all known human languages. At the core of ISO 639-3 are the individual languages already accounted for in ISO 639-2. The large number of living languages in the initial inventory of ISO 639-3 beyond those already included in ISO 639-2 was derived primarily from Ethnologue (15th edition). Additional extinct, ancient, historic, and constructed languages have been obtained from Linguist List. Administered by SIL",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/iwi-code"
},
"name" : "NZ Iwi",
"description" : "A FHIR CodeSystem of Iwi and iwi-related groups statistical classification",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/iwi"
},
"name" : "Iwi",
"description" : "New Zealand iwi codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/location-alias-type"
},
"name" : "Alias types",
"description" : "The complete set of alias types that apply to Locations and Organizations",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/loinc-nz-local-code"
},
"name" : "LOINC_NZ_local_code",
"description" : "A FHIR CodeSystem of NZPOCS Observation Code Set - NZ Specific Code",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/maoridescentcode"
},
"name" : "MÄori descent codes",
"description" : "Stats NZ's MÄori descent codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/mdr-26-0"
},
"name" : "MedDRA LLT 26.0 CS",
"description" : "FHIR CodeSystem for MedDRA LLT 26.0",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/mdr-27-0"
},
"name" : "MedDRA LLT 27.0 CS",
"description" : "FHIR CodeSystem for MedDRA LLT 27.0",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/meddra-code-26-0"
},
"name" : "MedDRA LLT 26.0 VS",
"description" : "FHIR ValueSet for MedDRA LLT 26.0",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/meddra-code-27-0"
},
"name" : "MedDRA LLT 27.0 VS",
"description" : "List of MedDRA codes suitable for use in New Zealand",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/meddra-code"
},
"name" : "MedDRA",
"description" : "MedDRA LLT",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/medication-snomed-absent-unknown-uv-ips"
},
"name" : "Medications - SNOMED CT + Absent/Unknown (IPS)",
"description" : "This value set includes the codes from SNOMED CT that are included in: descendants of 373873005 \\|Pharmaceutical / biologic product (product)\\|, excluding the descendants of 787859002 \\|Vaccine product (medicinal product)\\|, plus IPS codes for absent/unknown medications.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/medication-statement-status"
},
"name" : "Medication status codes",
"description" : "Medication Status Codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/medicine-doseform"
},
"name" : "Medicine Doseform - IPS",
"description" : "EDQM (European Directorate for the Quality of Medicines and Healthcare) Dose Form codes. This Value Set includes all the EDQM Standard Terms having: \n[Concept Status] = ‘Current’ AND \n[Concept Class] IN (‘PDF’, ‘CMT’, ‘CDF’, ‘PFT') AND \n[Domain] = 'Human and Veterinary' \n\nPDF = 'Pharmaceutical dose form'; CMT = 'Combined terms'; CDF = 'Combined pharmaceutical dose form'; PFT = 'Patient Friendly'",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/medicine-route-of-administration"
},
"name" : "Medicine Route of Administration - IPS",
"description" : "EDQM (European Directorate for the Quality of Medicines and Healthcare) Route of Administration codes. This Value Set includes all the EDQM Standard Terms having: \n[Concept Status] = ‘Current’ AND \n[Concept Class] = 'ROA' AND \n[Domain] = 'Human and Veterinary' \n\nROA = 'Route of administration'",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/my-document-mode"
},
"name" : "MyDocumentMode",
"description" : "Whether the application produces or consumes documents.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/my-new-cs"
},
"name" : "MyNewCS",
"description" : "My New CS",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nz-residency"
},
"name" : "NZ Residency status",
"description" : "Is the person a NZ resident",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-ctpp"
},
"name" : "NZMT - CTPP",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-mp-sps"
},
"name" : "NZMT MP (SPS)",
"description" : "NZMT MP (SPS)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-mp"
},
"name" : "NZMT - MP",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-mpp"
},
"name" : "NZMT - MPP",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-mpuu"
},
"name" : "NZMT - MPUU",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-tp"
},
"name" : "NZMT - TP",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-tpp"
},
"name" : "NZMT - TPP",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-tpuu"
},
"name" : "NZMT - TPUU",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzmt-type-code"
},
"name" : "NZMT Concept Type",
"description" : "NZMT concept type",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/nzpocs"
},
"name" : "NZPOCS",
"description" : "A LOINC FHIR ValueSet of NZPOCS Observation Code Set",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/observation-codes"
},
"name" : "LOINC Codes",
"description" : "This value set includes all LOINC codes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/observation-vitalsignresult"
},
"name" : "Vital Signs",
"description" : "This value set indicates the allowed vital sign result types. The LOINC code for Vitals Signs panel (85353-1) is a grouping structure for a set of vital signs and includes related links (with type=has-member) to the Observations in this set (e.g. respiratory rate, heart rate, BP). The Blood pressure panel (85354-9) is used to group the component observations Systolic blood pressure (8480-6) and Diastolic blood pressure (8462-4).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/pho-status"
},
"name" : "PHO",
"description" : "Primary Healthcare Organization",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/pho"
},
"name" : "PHO",
"description" : "Primary Healthcare Organization",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/practitioner-additional-authorisation"
},
"name" : "Additional Authorisation",
"description" : "Additional authorisations that a practitioner is authorised to practice or prescribe.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/practitioner-registration-status-code"
},
"name" : "Registration Status of Practitioners",
"description" : "The code list represents the current practicing status of the Provider Person as per their registration with an RA.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/practitioner-scope-of-practice"
},
"name" : "Scope of practice",
"description" : "A coded type for professional scope of practice.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/pregnancies-summary-uv-ips"
},
"name" : "Pregnancies Summary - IPS",
"description" : "IPS Pregnancies Summary",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/pregnancy-status-uv-ips"
},
"name" : "Pregnancy Status - IPS",
"description" : "IPS Pregnancy Status",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/problem-type-loinc"
},
"name" : "Problem Type (LOINC)",
"description" : "This value set indicates the level of medical judgment used to determine the existence of a problem.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/problem-type-uv-ips"
},
"name" : "Problem Type - IPS",
"description" : "This value set provides a category for the condition as a clinical problem for inclusion in the patient summary.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/problems-snomed-absent-unknown-uv-ips"
},
"name" : "Problems - SNOMED CT + Absent/Unknown - IPS",
"description" : "This value set includes codes from SNOMED Clinical Terms®: descendants of 404684003 \\|Clinical finding (finding) \\|, descendants of 243796009 \\|Situation with explicit context (situation)\\| and descendants of 272379006 \\|Event (event)\\| but excludes descendants of 71388002 \\|Procedure (procedure)\\|, as they are expected to be represented separately in the History of Procedures Section.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/problems-snomed-uv-ips"
},
"name" : "Problems (SNOMED CT) - IPS",
"description" : "This value set includes codes from SNOMED Clinical Terms®: descendants of 404684003 \\|Clinical finding (finding) \\|, descendants of 243796009 \\|Situation with explicit context (situation)\\| and descendants of 272379006 \\|Event (event)\\|. The descendants of 71388002 \\|Procedure (procedure)\\| (which were included in the CORE problem list) are not included, as they are expected to be represented separately in the History of Procedures Section.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/procedures-snomed-absent-unknown-uv-ips"
},
"name" : "Procedures - SNOMED CT + Absent/Unknown - IPS",
"description" : "This value set includes codes from SNOMED Clinical Terms®: descendants of 71388002 \\|Procedure (procedure)\\|, excluding [all subtypes of 14734007 \\|Administrative procedure (procedure)\\|, all subtypes of 59524001 \\|Blood bank procedure (procedure)\\|, all subtypes of 389067005 \\|Community health procedure (procedure)\\|, all subtypes of 442006003 \\|Determination of information related to transfusion (procedure)\\|, all subtypes of 225288009 \\|Environmental care procedure (procedure)\\|, all subtypes of 308335008 \\|Patient encounter procedure (procedure)\\|, all subtypes of 710135002 \\|Promotion (procedure)\\|, all subtypes of 389084004 \\|Staff related procedure (procedure)\\|], plus IPS codes for absent/unknown procedures.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/procedures-uv-ips"
},
"name" : "Procedures (SNOMED CT) - IPS",
"description" : "This value set includes codes from SNOMED Clinical Terms®: descendants of 71388002 \\|Procedure (procedure)\\|, excluding [all subtypes of 14734007 \\|Administrative procedure (procedure)\\|, all subtypes of 59524001 \\|Blood bank procedure (procedure)\\|, all subtypes of 389067005 \\|Community health procedure (procedure)\\|, all subtypes of 442006003 \\|Determination of information related to transfusion (procedure)\\|, all subtypes of 225288009 \\|Environmental care procedure (procedure)\\|, all subtypes of 308335008 \\|Patient encounter procedure (procedure)\\|, all subtypes of 710135002 \\|Promotion (procedure)\\|, all subtypes of 389084004 \\|Staff related procedure (procedure)\\|].",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/purposeofuse"
},
"name" : "NZ purpose of use",
"description" : "Reason for performing one or more operations on information, which may be permitted by source system's security policy in accordance with one or more privacy policies and consent directives. Usage Notes: The rationale or purpose for an act relating to the management of personal health information, such as collecting personal health information for research or public health purposes.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/reaction-event-severity"
},
"name" : "AllergyIntoleranceSeverity",
"description" : "Clinical assessment of the severity of a reaction event as a whole, potentially considering multiple different manifestations.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/reason-medication-status-codes"
},
"name" : "SNOMED CT Drug Therapy Status codes ",
"description" : "This value set includes some taken and not taken reason codes from SNOMED CT - provided as an exemplar",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/result-coded-value-pathology-uv-ips"
},
"name" : "Results Coded Values Pathology - IPS",
"description" : "This value set includes codes from SNOMED Clinical Terms (SNOMED CT®) that are included in: all descendants of 106253005 \\|Histologic grading differentiation AND/OR behavior (qualifier value)\\|, all descendants of 373369003 \\|Finding of histologic grading differentiation AND/OR behavior (finding)\\|, all descendants of 399981008 \\|Neoplasm and/or hamartoma (disorder)\\|.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-blood-group-uv-ips"
},
"name" : "Results Blood Group - IPS",
"description" : "Blood group [Type]",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-coded-values-laboratory-uv-ips"
},
"name" : "Results Coded Values Laboratory - IPS",
"description" : "This value set is defined as the union of: (a) Blood group [Type]; (b) Presence/Absence Indicators (2.16.840.1.113883.11.22.52) (c) Microorganisms (2.16.840.1.113883.11.22.49)",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-laboratory-observations-uv-ips"
},
"name" : "Results Laboratory Observation - IPS",
"description" : "Value Set Definition: LOINC {STATUS in {ACTIVE}, CLASSTYPE in {1}, CLASS exclude {CHALSKIN, H&P.HX.LAB, LABORDERS, NR STATS, PATH, PATH.\\*, MOLPATH, MOLPATH.\\*, CYTO, HL7.CYTOGEN, HL7.GENETICS}}",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-microorganism-uv-ips"
},
"name" : "Results Microorganism - IPS",
"description" : "This is a value set of the SNOMED CT microorganism concepts for use in the Results section observation values.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-pathology-observations-uv-ips"
},
"name" : "Results Pathology Observation - IPS",
"description" : "\n Value Set Definition:\n\n LOINC {STATUS in {ACTIVE}, CLASSTYPE in {1}, CLASS in {CYTO, HL7.CYTOGEN, HL7.GENETICS, MOLPATH, MOLPATH.\\*, PATH, PATH.\\*}}",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-radiology-numobs-snomed-dicom-uv-ips"
},
"name" : "Results Radiology Measurement Observation (SNOMED-DICOM) - IPS",
"description" : "Extensible value set including SNOMED CT and DICOM concepts for Linear, Area and Volume Measurements",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-radiology-observations-uv-ips"
},
"name" : "Results Radiology Observation - IPS",
"description" : "\n Value Set Definition: \n LOINC {CLASS in {RAD}}",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-radiology-txtobs-snomed-dicom-loinc-uv-ips"
},
"name" : "Results Radiology Textual Observations (SNOMED-DICOM-LOINC) - IPS",
"description" : "IPS Results Radiology Textual Observations",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/results-specimen-type-uv-ips"
},
"name" : "Results Specimen Type - IPS",
"description" : "IPS Specimen Type value set. This value set includes a set of codes from SNOMED CT that may be used to represent specimen types.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/scopeOfPractice"
},
"name" : "Scope of practice",
"description" : "A classification of the type or range of health services that a practitioner is authorised to provide, as determined by the Responsible Authority or other statutory authority (e.g. PHARMAC), that is, what the practitioner can or cannot do. It includes Scope of Practice as defined by the Health Practitioners Competence Assurance Act 2003, any special authorisations granted, and any conditions or limitations imposed by the Responsible Authority.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/target-diseases-uv-ips"
},
"name" : "Vaccine Target Diseases - IPS",
"description" : "This value set includes the codes from SNOMED CT describing Vaccine Target Diseases.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/target-site-uv-ips"
},
"name" : "Target Site - IPS",
"description" : "This value set includes codes from SNOMED Clinical Terms®: all descendants of 442083009 | Anatomical or acquired body structure (body structure)|.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/test-omaha-system"
},
"name" : "Omaha System CodeSystem",
"description" : "Omaha System CodeSystem including various domains.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ucum-common"
},
"name" : "Common UCUM units",
"description" : "Commonly encountered UCUM units (for purposes of helping populate look ups.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ucum-vitals-common"
},
"name" : "Vital Signs Units",
"description" : "Common UCUM units for recording Vital Signs",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/ukpul-vs"
},
"name" : "UKPUL",
"description" : "FHIR ValueSet for UKPUL",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/v3-ActReason"
},
"name" : "v3 Code System ActReason",
"description" : " A set of codes specifying the motivation, cause, or rationale of an Act, when such rationale is not reasonably represented as an ActRelationship of type \"has reason\" linking to another Act. Examples:\r\nExample reasons that might qualify for being coded in this field might be: \"routine requirement\", \"infectious disease reporting requirement\", \"on patient request\", \"required by law\".",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/v3-ucum"
},
"name" : "Unified Code for Units of Measure (UCUM)",
"description" : "The Unified Code for Units of Measure (UCUM) is a code system intended to include all units of measures being contemporarily used in international science, engineering, and business. The purpose is to facilitate unambiguous electronic communication of quantities together with their units. The focus is on electronic communication, as opposed to communication between humans. A typical application of The Unified Code for Units of Measure are electronic data interchange (EDI) protocols, but there is nothing that prevents it from being used in other types of machine communication.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/vaccine-code"
},
"name" : "Vaccine Administered Value Set",
"description" : "This identifies the vaccine substance administered - CVX codes.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "ValueSet"
}
],
"reference" : {
"reference" : "ValueSet/vaccines-uv-ips"
},
"name" : "Vaccines - IPS",
"description" : "This value set provides a list of types of vaccine, plus IPS codes for absent/unknown immunizations. It includes codes from SNOMED Clinical Terms®: all descendants of 787859002 \\|Vaccine product (product)\\|.",
"exampleBoolean" : false
}
],
"page" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-page-name",
"valueUrl" : "toc.html"
}
],
"nameUrl" : "toc.html",
"title" : "Table of Contents",
"generation" : "html",
"page" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-page-name",
"valueUrl" : "index.html"
}
],
"nameUrl" : "index.html",
"title" : "Home",
"generation" : "markdown"
}
]
},
"parameter" : [
{
"code" : "path-resource",
"value" : "input/capabilities"
},
{
"code" : "path-resource",
"value" : "input/examples"
},
{
"code" : "path-resource",
"value" : "input/extensions"
},
{
"code" : "path-resource",
"value" : "input/models"
},
{
"code" : "path-resource",
"value" : "input/operations"
},
{
"code" : "path-resource",
"value" : "input/profiles"
},
{
"code" : "path-resource",
"value" : "input/resources"
},
{
"code" : "path-resource",
"value" : "input/vocabulary"
},
{
"code" : "path-resource",
"value" : "input/maps"
},
{
"code" : "path-resource",
"value" : "input/testing"
},
{
"code" : "path-resource",
"value" : "input/history"
},
{
"code" : "path-resource",
"value" : "fsh-generated/resources"
},
{
"code" : "path-pages",
"value" : "template/config"
},
{
"code" : "path-pages",
"value" : "input/images"
},
{
"code" : "path-tx-cache",
"value" : "input-cache/txcache"
}
]
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.